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This thesis focuses on the study of powder and granule characterization in order to improve the 
formulations and properties of solid oral dosage forms as final products. The main goal is to 
investigate the effect of excipients on formulation, granule properties and morphology and on the 
active pharmaceutical ingredient (API) release rate of final products. Release rate and controlled-
release behaviour of drugs are considered as the main quality attributes of products in this project. A 
natural biopolymer, Alcell lignin is used as an excipient to modify formulations and granule 
properties in order to improve the final quality of products. In addition, the effect of lignin on drug 
release and controlled release behaviour is studied. 
Firstly, powder and granule properties are investigated using dry granulation by the roll compaction 
process considering various formulations and process parameters. Then, tablet properties are studied 
using dry granulation via the roll compaction process, considering lignin as excipient and 
acetylsalicylic acid as API. The influence of lignin on the drug release rate is assessed using gastric 
fluid (pH 1.2). 
Subsequently, artificial neural network (ANN) is applied for the prediction of drug release. ANN is 
developed considering the following parameters: roll pressure, screw speed and lignin content. The 
model was developed and validated through comparison with obtaind experimental data. 
Compatibility was observed, thereby confirming the model as a predictive model tool for release rate 
determination. 
Finally, the controlled release behaviour of drugs are investigated considering modified lignin as an 
excipient using varying formulations. Here, paracetamol is considered as an API in all formulations. 
The results show the positive influence of adding modified lignin as an excipient, as it increases the 
drug release rate. Moreover, controlled release behaviour of drugs is investigated at different pH, 
gastric (pH 1.2) and intestine fluid (pH 7.2)   and results show pH-sensitive behaviour when modified 
lignin is utilised in the formulation lignin. 
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The thesis is presented in “thesis by publication” format. Each chapter corresponds to a published 































Recently, a number of researchers have focused on Alcell lignin for use in pharmaceutical studies 
because of its low toxicity, biodegradability and biocompatibility properties. Various functional 
groups in the lignin structure including; phenolic, aliphatic hydroxyl and carboxyl groups offer the 
possibility for chemical modifications for drug delivery and controlled release. The goal of this 
project is the use of lignin as natural biopolymer in order to improve formulation and granule 
properties, as well as, investigative its role in drug release rate and controlled release behaviour. 
Chapter 1 introduces a process map, which shows a relation between process parameters, and quality 
attributes of products using different formulations. Dry granulation by roll compaction is used to 
produce granules. Alcell lignin is added as an excipient to improve formulations properties. The 
critical process parameters, which are considered in roll compaction processes are roll pressure and 
screw speed. The key quality attributes are ribbon density and granule size distribution. The relation 
between process parameters and quality attributes are mapped using JMP software. Powder 
characterization is carried out considering different excipients and formulations, then mapped, in 
order to explain the relation between powder process parameters and ribbon density. Afterwards, the 
relation between roll pressure and screw speed as process parameters with d50 of granules are 
mapped. The results illustrate that, roll pressure is the critical process parameter, an increase in roll 
pressure leads to an increase in the ribbon density and D50 of granules. 
Chapter 2 investigates the tablet properties and drug release rate using different excipients and 
acetylsalicylic acid as API. Dry granulation by roll compaction is carried out to produce granules. 
The main focus of this study is to determine the influence of lignin as a natural biopolymer on the 
drug release rate in gastric fluid considering two different formulations. The drug release rate 
investigation is performed utilizing dissolution and disintegration tests using medium buffer with pH 
of 1.2. Results show higher release rate, faster disintegration time and higher hardness for the 
formulation containing lignin. Higher release rate of tablets with lignin formulation are due to the 
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amorphous structure of lignin and its interaction with the API, which improves drug solubility and 
therefore bioavailability, the key factor in oral dosage development. On the other hand, higher roll 
pressure leads to more densified ribbons associated with lignin blends and consequently, larger 
granules are produced. These larger granules result in porous tablets, which leads to faster 
disintegration times as solute diffuses faster into the tablets. Also, the higher hardness for  tablets 
containing lignin is attributed to better affinity between lignin and MCC which leads to lignin acting 
as a tablet binder.  
Chapter 3 focuses on modelling of drug dissolution release rate and the effect of lignin using dry 
granulation by roll compaction process. An artificial neural network (ANN) model considers two 
hidden layers and combines various activation functions, i.e. linear, hyperbolic tangent, and Gaussian 
is applied to develop a model in order to design and predict the drug release rates. In order to 
investigate the effect of lignin as a natural biopolymer on the drug release rate, two different 
formulations are considered, one with lignin and another without lignin. Lignin is added as an 
excipient in order to study the bioavailability enhancement of the poorly water-soluble drug. The 
results of release rate indicated that the tablets containing lignin have higher release rates of API. The 
results of ANN modelling revealed that the developed model could predict the release rate with high 
accuracy and R2=0.99 was obtained for most cases. The model was used to predict the kinetics and 
equilibrium of the release rate and suitable agreement was obtained between the predicted and 
measured data. The validated model was then used to understand the effect of process parameters on 
the release rate, and it was revealed that increasing roll pressure decreases the release rate, because 
larger granules are produced which in turn results in lower release rate. 
Chapter 4 progresses the controlled release behaviour and pH-sensitive properties of drug using 
modified lignin as an excipient. Three different formulations are considered to study the effect of 
modified lignin on drug pH-sensitive behaviour and controlled release properties. The first 
formulation contains microcrystalline cellulose (MCC101) as excipient and paracetamol as active 
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pharmaceutical ingredient (API). The second formulation includes Alcell lignin and MCC 101 as 
excipient and paracetamol, and the third formulation consists of carboxylated Alcell lignin, MCC 101 
and paracetamol. Due to different functional groups in lignin structure, it is known as a suitable 
candidate for functionalization. Here lignin modification is carried out by increasing carboxyl groups 
on the lignin structure. FTIR analysis is performed to show the successful lignin functionalization. 
Afterwards, in order to investigate the pH-sensitive properties of drug release, dissolution tests are 
performed on gastric and intestinal fluid, i.e. pH 1.2 and pH 7.2 respectively. The results illustrated 
the pH- responsive behaviour for formulation containing modified lignin. Drug release rate is studied 
by dissolution tests for different formulations using buffer solution with pH 5.8, as mentioned in 
United States pharmacopeia (USP 23). The results showed higher release rate for the formulation 
containing carboxylated lignin.  
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Abstract 
In this study, a process map was developed in an effort to improve the understanding of dry 
granulation of pharmaceutical excipients by roll compaction process, and to implement the quality-
by-design (QbD) approach. Through development of the process map, a correlation was made 
between the critical process parameters (roll pressure, screw speed), and critical quality attributes 
(density of ribbons and granule size). This method reduces development time, quantity of materials 
required and cost. A new excipient formulation based on natural polymers (lignin and cellulose) was 
utilised to improve the properties and reduce costs associated with tablets production. A variety of 
lignin, microcrystalline cellulose (MCC) and lactose monohydrate formulations were compacted 
followed by milling to obtain granules. Formulations were also characterised in terms of 
compressibility and flowability. Density of ribbons as well as granule size distribution were mapped 
versus critical process parameters. Based on this work as initial study, roll pressure was found to be 
a critical process parameter, higher ribbon density and larger granule size obtained with higher roll 
pressure. It was also revealed that the process map is a powerful tool in understanding the dry 




Keywords: Dry Granulation; Roll Compaction; Critical Process Parameters; Critical Quality 
Attributes; Quality by Design; Process Map; Natural Excipient; NIR Spectroscopy 
1. Introduction 
The current practice in pharmaceutical manufacture is batch wise in which trial and error approach, 
which is time-consuming and wasteful is used for new formulations and equipment. Recently, 
continuous processing has received more attention in the pharmaceutical industry as it offers superior 
characteristics compared to batch processing [1]. Upon developing continuous processing, we can 
avoid scale-up issues, reduce cycle times, variability and production costs, ensure faster product 
release, increase flexibility and efficiency, and improve product quality [2, 3]. Underpinning research 
is required to transform batch mode operation to the continuous mode. One of the key processing 
steps in the pharmaceutical manufacturing is granulation, as the properties of final products are 
dependent on the granule properties. In the manufacturing process, active pharmaceutical ingredients 
(API) and excipients mixtures are granulated to improve flowability and content uniformity of the 
particles. There are two main methods for granulation of pharmaceutical formulations, namely dry 
and wet granulation [4, 5]. In wet granulation, liquid binders are used to form granules from fine 
powder, whereas in dry mode no binder is required. Indeed, dry granulation is useful for compounds 
that are sensitive to heat and moisture [6-8]. Roll compaction (RC) is widely used for dry granulation 
as a continuous process, and has shown more advantages, for example, a reduction in powder 
segregation and increasing bulk density [7, 9-11]. 
During roll compaction, fine powder is compacted between two counter-rotating rolls to produce 
ribbons (briquette) by applying hydraulic force on powder. The ribbons are milled to produce 
granules, and then compacted to form tablets [11, 12]. As such, controlling ribbon density and granule 
size are critical in RC process. Therefore, application of RC would promote the paradigm of 
continuous pharmaceutical manufacturing. In order to develop a continuous line for manufacturing 
of solid-dosage forms, the process understanding is of great importance so that the critical quality 
attributes of products are correlated with the process parameters and material properties [13-16]. 
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The mechanism of the dry granulation process is still not well understood in the continuous 
pharmaceutical manufacturing context. Several models have been deployed such as Johanson model, 
slab method, finite element method, discrete element method and artificial neural network to correlate 
the process parameters with ribbon density. These models are of mathematical basis and are used to 
predict process variations [8, 11-13, 16, 17]. In addition, several researchers have studied different 
aspects of RC to understand the effect of process parameters on ribbon density [18-23]. 
McAuliffe et al. [24] studied the effect of roll pressure on density of ribbons prepared with a 
formulation containing MCC 102, anhydrous lactose, and they highlighted the impact of roll pressure 
on ribbon and granule properties at constant screw and roll speed with variable roll gap. They 
mentioned increasing the roll pressure causes decrease in the roll gap. In addition, it was shown that 
increasing the roll pressure, have a significant effect on ribbon and granule properties. Souihi et al. 
[25] investigated the influence of process parameters on ribbon density using the Johanson model for 
the formulation containing paracetamol, mannitol, and MCC 102. They mentioned that Johanson 
model describes the effect of roll pressure and screw speed on ribbon density and emphasised the 
minor effect of roll gap on ribbon density compared to roll pressure. Khorasani et al. [21] also studied 
the effect of roll pressure and roll speed on ribbon density utilising a formulation containing MCC 
101 and acetylsalicylic acid with the constant roll gap. Moreover, the screw speed was adjusted 
automatically to keep the roll gap constant. It was also shown that increasing the roll pressure leads 
to increase the ribbon density and granule size. On the other hand decreasing the roll speed results in 
increasing ribbon density and granule size due to increased residence time of powder between rolls. 
Kumar et al. [26] studied the influence of process parameters on quality attributes of the wet 
granulation process by developing a regime map for a formulation consisting of α-Lactose 
monohydrate and PVP. It was shown that the regime map provides a design space for optimisation of 
granulation. Sajjia et al. [2] analysed the effect of process parameters on ribbon density using of MCC 
102, and further explained the effect of roll pressure and screw speed on ribbon density. They believed 
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that increasing the roll pressure leads to ribbons with higher density. They further highlighted the 
unstable and minor effect of screw speed on ribbon density. 
As mentioned, different researchers have studied the effect of process parameters on ribbon density 
and particle size of granules, but development of a comprehensive process map, which is capable of 
providing a design space for roll compaction process, is of great importance. Furthermore, the effect 
of formulation on the ribbon and granule properties has not been studied. None of these investigations 
have shown the correlation between process parameters and quality attributes by mapping the process, 
and understanding the influence of material formulation.  
Indeed, a comprehensive understanding the process for various formulations is of great importance. 
In order to determine the best design space in dry granulation processing, one may need to use a wide 
range of DoE (design of experiments) to fully understand the effect of underlying parameters on 
ribbon properties as well as granule size. Development of a design space for dry granulation can be 
achieved with a process mapping, which correlates the process input to the outputs for a wide range 
of formulations. Recently, several researchers have attempted to show the importance of identifying 
the interaction between process parameters of materials and quality attributes of products for roll 
compaction process. They have utilised dimensionless variables for roll compaction, and regime maps 
for wet granulation, then processing have been investigated [15, 23, 26-28]. The process map has 
been successfully developed for wet granulation via twin-screw extruder [26], and it was shown that 
the process map concept is of great importance for the development of continuous manufacturing. 
Therefore, it would be of great importance to develop a process map for dry granulation by roller 
compactor considering new formulations. 
Lately, due to different issues in terms of side effects and drug release, use of natural polymers has 
attracted much attention on the development of tablet formulations through usage of new excipients. 
Natural polymers offer a number of advantages as excipients in tablet manufacture including; low or 
no toxicity, regulatory compliance and stability, while enhancing the physicochemical properties of 
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powders and increasing drug release rates. Due to the high chemical functionality of lignin, it can be 
introduced as a novel excipient for development of new materials [29-37]. 
In the present study, a process map has been developed for RC processing with various formulations 
including the novel lignin excipient. Different formulations with differing percentages of 
microcrystalline cellulose (MCC), lactose and Alcell lignin were designed and used throughout the 
experiments. For designing the process map, a correlation between input variables including roll 
pressure, screw speed, and ribbon properties such as density as well as D50 of granules was found. 
This method reduces development time, quantity of materials and cost. It should be noted that these 
process maps are a preliminary study and are limited to the specific type of formulations and 
equipment used in the experimental design. Moreover, in order to assess the applicability of NIR 
spectroscopy as a PAT tool for on-line monitoring of RC, the density of ribbons containing bio-based 
materials were analysed using the NIR method. However, it was conducted as an off-line experiment 
and for limited samples. 
2. Experimental procedure 
2.1. Materials and methods 
Microcrystalline cellulose (MCC SANAQ® 102 L USP/NF/EP), lactose monohydrate (Lennox USP, 
NF, BP, Ph, pure pharma grade) and Alcell lignin (Tecnaro, Ilsfeld, Germany) were used as excipients 
throughout the experiments. In order to prepare the excipient mixtures, microcrystalline cellulose, 
lactose monohydrate and Alcell organosolv lignin were mixed with 0.5 % w/w magnesium stearate 
(Sigma-Aldrich), which acted as lubricant. For further details on the lignin used in this study the 
authors are referred to [38]. Two different formulations were considered, first, MCC was mixed with 
5, 10 and 20 wt. % of lactose, and then MCC was mixed with 5, 10 and 20 wt. % of Alcell lignin. All 
components were blended using a Morphy Richards Stand Mixer with beater attachment at speed 
setting 3 (100 RPM approx.) for 15 min. 
2.2. Equipment and analysis 
A top-fed roller compactor Freund TF-MINI (Vector Corporation, Japan) (see Figure 1) with a 
vertical screw feeder was utilised throughout the RC experiments. The width and diameter of rolls 
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were 25 and 100 mm, respectively. The roll speed was set at 4 rpm for all experiments. Process 
parameters, screw speed (SS) and roll pressure (RP), were changed with variable screw speed (8-18 
rpm) by 2 rpm step and roll pressure (10-50 bar) by 5 bar step. An envelope density analyser, (GeoPyc 
1360, Micromeritics Instrument Corp. 4356 communications Drive, Norcross, GA 30093, USA) was 
used to measure the ribbon density. The roll gap was uncontrolled and variable during the 
experiments. The thickness of produced ribbons was measured to be between 1 – 3 mm for all 
samples. 
In addition, a multipoint Near-Infrared (NIR) spectrometer (Innopharma, Ireland), Multieye NIR, was 
utilised to characterise the ribbon density. The NIR spectra were calibrated using the density obtained 
via the GeoPyc instrument and developing a calibration model. Partial Least Square (PLS) technique 
was used for calibration of NIR results. The produced ribbons were milled with a conical mill 
(Laboratory Comil 193 AS, Quadro, USA) with 813-µm mesh size at 3000-rpm mill speed to produce 
granules. 
The particle size distribution (PSD) of powders and post-milling granules were measured using 
Microtrac S3500 particle size analyser (Malvern, USA). Powder flow and compressive behaviour of 
materials were evaluated using powder flow rheometer (FR4, Freeman Technologies, UK). For 
characterising the morphology of powders, scanning electron microscopy (SEM) was performed 
under vacuum. Particle shape and surface morphology of the powders were examined using a 
scanning electron microscope (Hitachi TM-1000 desktop SEM, USA). Schematic representation of 










3. Results and discussions 
3.1. Effect of process parameters on ribbon density 
In order to implement the quality by design (QbD) approach for roll compaction process, first, a 
relationship between process parameters and quality attributes of products should be defined. For 
developing a basic understanding of dry granulation process by roller compactor, the effect roll 
pressure and screw speed on ribbon envelope density are plotted by using JMP 12 pro software and 
shown in Figure 2. As expected, the ribbon envelope density is greatly influenced by roll pressure, 
while screw speed has minor effect on the density. 
It should be pointed out that in some cases, insufficient data were collected due to process limitations 
at these operating conditions. It is observed that applying more roll pressure, at constant screw speed, 
leads to denser powders, and consequently produced ribbons with higher density for all samples. 
Higher roll pressure under constant screw speed leads to more compaction between two rotating rolls 
and thereby higher density of ribbons. In other words, in constant screw speed, the amount of powders 
and powder residence time between the rolls are constant as well, and more pressure results in more 
roll force and more densification of ribbons. The graphs of different percentages of lactose illustrate 
wide range of process parameters, while the graphs with lignin show more limitations in terms of 
screw speed. 
Furthermore, it is observed that at the same content of lactose and lignin in the formulation, higher 
ribbon density is obtained for the formulation containing lignin, which could be attributed to the 
intrinsic physical and chemical properties of lignin, such as amorphous and cross-linked structure   
and interaction with MCC, which will be further investigated in the next section. On the other hand, 
as it can be seen in Figure 2, screw speed has a minor influence on the ribbon density for all 
formulations. For each formulation with the same roll pressure, increasing the screw speed results in 
increased ribbon density, although slightly. As shown in Figure 2, more limitations of process 
parameters are observed for higher percentages of lactose formulation. The results confirm that lignin 
is a promising bio-based excipient for tablet manufacturing and almost similar behaviour with 
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common excipients (e.g. lactose) was observed for the formulations containing lignin.
 
 
Figure 2. Effect of process parameters on ribbon density for various formulations. 
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3.2. Effect of formulation on density of ribbons 
To investigate the effect of the formulations used on the density of the produced ribbons, contours of 
density versus roll pressure and screw speed for different formulations are plotted as shown in Figures 
3 and 4. These contours show the two-dimensional colour representation for the relationship between 
































Figure 4. Contours Plot for Density (g/cc), Formulation= 5, 10 and 20 % Alcell lignin.  
Figure 3 shows the contours of formulation with lactose at different percentages in which the white 
area, at the background of the map, indicates the process limitations. The latter means that the 
experiments cannot be conducted due to operational problems such as roller blockage, over 
compaction, etc. In terms of blockage of materials, it happened at the end of screw feeder, the neck 
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of hopper, in the slip region (see Fig. 1). As such, these contours also indicate the workability of RC 
in which the colour areas correspond to the working conditions of equipment. 
It is observed that increasing the percentage of lactose results in higher density and less limitation in 
the process parameters. Furthermore, by increasing the percentage of lactose, the effects of screw 
speed on ribbon density decay. At 5% of lactose, increasing the screw speed leads to enhancing the 
density of ribbon slightly, whereas for 10% of lactose, the screw speed influence is slight, and for 
20% of lactose it does not have any appreciable effect (see Figure 3) which is in agreement with 
literature [8, 24]. 
Figure 4 illustrates the contours of formulations with different percentages of Alcell lignin including 
5, 10 and 20 wt. percentage. The plots show less limitation in terms of roll pressure specifically with 
higher percentage of Alcell lignin. Therefore, addition of lignin would improve the process in terms 
of limitation and a vast range of process parameters can be used for the formulations containing lignin. 
In terms of the effect of process parameters on ribbon density, higher roll pressure results in higher 
ribbon density for all percentages of Alcell lignin. Nevertheless, the effect of screw speed on ribbon 
density is almost negligible. Increasing the screw speed while keeping the roll pressure constant, does 
not have considerable effect on ribbon density for formulations containing lignin. Given that the roll 
gap was variable in the experiments, increasing the screw speed increases the amount of powder 
pushed between the rolls, therefore, the gap between the rollers increases which corresponds to the 
increase of the ribbon thickness. Now, increasing the ribbon thickness decreases the stress applied on 
the powder as the force will be distributed over wider thickness of powder. However, this 
phenomenon is not envisaged to be significant compared to the effect of roll force. 
In order to understand the behaviour of various formulations during the roller compaction process, 
the Stability Index (SI) of different blends were measured by FT4 powder rheometer. The stability 
index of 1 is ideal and implying that the material does not change during the characterisation. An 
appropriate explanation is provided in the Appendix about the stability index. The SI of the blends, 
containing 5%, 10% and 20% lignin were 0.729, 0.752, and 0.840 respectively. It implies that by 
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increasing the lignin content in the blends, the stability of the powder blends increases. Moreover, the 
contours graphs show the higher stability for the blends with higher lignin percentage. On the other 
hands, the stability index was measured for the lactose blends as well. The SI of 5%, 10% and 20% 
lactose were 0.891, 0.714 and 0.587 respectively. These results illustrate that increasing the lactose 
percentage, leads to decrease in the blend stability. 
For better understanding, the effect of formulations and materials on quality attributes of roll 
compaction process, flowability and cohesion for different materials used in this work were measured 
by FT4 powder rheometer and represented in Figure 5. 
 
Figure 5. Cohesion and flow function graphs for Lactose, Alcell lignin and MCC 102 measured by FT4 
powder rheometer 
It is observed that Alcell lignin has a better flowability (Flow Function=6.38, easy flow) than lactose 
(FF=3.54, poor flow). The methods and equations used for measuring powder flowability are 
described in Appendix A. On the other hand, lactose has greater cohesion (1.27 kPa) than Alcell 
lignin (0.611 kPa) and MCC (0.384). To analyse the effect of particle size and shape on the properties 
of materials, PSD and SEM characterisations were carried out. Figure 6 presents the particle size 
distribution and SEM of the three used excipients. Image A and PSD of lactose show a wide range of 
particle size, which results in poor flow behaviour. Image C and PSD of Alcell lignin illustrates a 
wide range of particle size, similar to lactose, but with lower cohesion which causes easy flow. On 
the other side, image B and PSD of MCC 102 demonstrates a narrow particle size distribution, which 
31 
 
leads to free flow behaviour. As it is demonstrated in the particle size graph, lactose and lignin have 
almost similar particle size (D50=37 microns), but MCC 102 has larger particles with a narrower 
range of particle sizes with more uniformity and higher flowability. In addition, Figure 7 indicates 
the results of compressibility of the excipients measured by FT4 powder rheometer via 
compressibility test. Compressibility is a useful indicator of powder flowability, if it is cohesive or 
free flowing [39, 40]. 
 




Figure 7. Compressibility of Lactose, MCC 102 and Alcell lignin measured by FT4 powder rheometer. 
 
As seen in Figure 7, lactose shows the highest compressibility among all excipients, while MCC 102 
has the lowest compressibility. The reason to use lactose/lignin as excipient is to improve the 
compaction behaviour of MCC 102 in the manufacturing process. Also, it is seen that lignin can be 
used to improve the compressibility of MCC 102 during the RC process. 
The process map indicates that higher compressibility leads to a wide range of process parameters for 
different formulations containing lactose. However, lactose is cohesive material and poor flowing, 
and introducing lignin can improve the flow behaviour of formulation.  A wide range of screw speeds 
for the blends with different percentages of lactose are shown in Figure 3 [29-31]. For the lignin, low 
range of screw speed can be applied during the process (see Figure 4). It means that at higher screw 
speed, more powders are pushed between the rolls and increasing screw speed would result in 
blockage due to less compressibility of lignin compared to lactose. On the other hand, higher screw 
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and MCC, lignin has higher cohesion, and increasing the percentage of lignin would result in less 
process limitations. The higher ribbon density for formulations containing lignin as observed in 
Figure 4, can be attributed to the affinity and interaction between lignin and MCC 102 as both 
materials are of cellulosic nature. 
Physical properties of powders have an important influence on the quality attributes of products. We 
have to investigate the physical properties of materials and the behaviour of them as a component in 
the formulations. There is a relationship between particle size of powders as an inherent properties 
and their surface area. Materials with smaller particles have larger surface area, which cause them to 
be more compressible than the material with larger size. Therefore, lactose with smaller particle size 
indicates increased particle-particle contact which tends to be more compressible compared to MCC 
102. For lactose, by increasing applied stress the compressibility increases due to smaller size which 
results in more efficient inter-particle packing. 
To further understand the effect of blends properties on quality attributes of products, the results of 
different blends characterisation by FT4 powder rheometer are demonstrated in Figure 8. The results 
confirm that blends with differing lactose percentages have higher compressibility than the blends 
with differing Alcell lignin percentages. For example, as shown in the Figure 8A, due to the highest 





















Figure 8. Graphs of compressibility (CPS) of different blends measured by FT4 powder rheometer. 
 
3.3. Effect of process parameters on D50 of granules 
Another critical quality attribute for dry granulation using roll compaction is granule size, as the tablet 
properties are dependent on the granule size. The produced ribbons were then milled to obtain the 
desired granules. For this section, D50 of granules (median size) was used as representative granule 
size. The effect of process parameters on D50 of granules for different formulations are illustrated in 
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Figures 9 and 10. These maps are plotted by using JMP 12 pro software (SAS institute) for D50 of 
granules versus roll pressure and screw speed. Figure 9 illustrates the correlation between process 
parameters and D50 of granules for 5, 10 and 20 percentages of lactose. For each formulation, higher 
roll pressure leads to greater D50 at constant screw speed. As discussed, because of smaller particle 
size of lactose compared to MCC 102, the blends containing lactose are more compactible. Increasing 
the lactose percentage leads to denser ribbons, and consequently results in larger granules because 
more shear force is needed to break up the ribbons in the mill for granule formation. In addition, it is 
seen that the effect of screw speed on D50 at constant roll pressure is almost negligible. Moreover, 
in the highest percentage of lactose (20 %), due to inherent properties of lactose such as cohesion, a 
narrow range of screw speed and a wide range of roll pressure are observed. Due to higher cohesion 
of lactose than MCC 102, in the higher percentage of lactose, there are more limitations.  In Figure 
10, the correlation between process parameters and D50 of granules for 5, 10 and 20 percentages of 
Alcell lignin are shown. These maps present a narrow range of screw speed and a wide range of roll 
pressure for these formulations. Because of Alcell lignin properties including less compressible and 
less cohesion, smaller D50 of granules were observed for formulations containing lignin. On the other 
hand, for different formulations of Alcell lignin, increasing the percentage of lignin leads to larger 
D50 of granules because of smaller particle size of lignin than MCC 102, higher compressibility and 





































Figure 10. Effect of process parameters on D50 of granules for Alcell lignin formulations. 
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3.4. Effect of formulation on D50 of granules 
The contours of D50 of granules versus roll pressure and screw speed are designed for different 
formulations of lactose and Alcell lignin, as shown in Figures 11 and 12. These maps describe the 
limitations of process parameters and equipment as discussed before. The generation of uncontrolled 
fines is a common problem in dry granulation process. During milling process to produce granules, 
the particles, which are ≤125 m, are known as fines [41]. In addition, the area in the process map 
with particle size smaller than 125 micron for each formulation reveals the amount of fines produced 
which should typically be avoided. 
Figure 12 indicates the correlation between process parameters and D50 of granules for different 
percentages of Alcell lignin. The same trend was observed for formulation with Alcell lignin. Higher 
percentages of Alcell lignin leads to larger particle size of granules and less percentage of fines. As 
discussed before, the compressibility of different blends with lactose are higher than Alcell lignin. It 
is concluded that, higher compressibility of lactose formulations leads to produce denser and stronger 
ribbons, then, larger granule size. Less percentage of fines and bigger granule size are observed with 
20 wt. % of Alcell lignin compared to lower lignin content. Also, as seen, higher roll pressure leads 
to greater D50, while as mentioned before, screw speed does not have any serious effect on D50. 
These plots, Figures 11 and 12, also show that the amount of fines (particles ≤ 125 micron) are 
dependent on the roll pressure, increasing the roll pressure leads to denser powders, and larger granule 
size, result in a reduction in the amount of fines. At a constant roll pressure, increasing the screw 
speed results in enhancement of the particle size of granules for 5 and 10 wt. % of lactose formulation. 
However, for 20% of lactose, the screw speed does not have any important influence on particle size 
of granules, in addition, the map shows more stability. By increasing the roll pressure, the influence 




























Figure 12. Contour plot for d50 of granules (microns), formulation=5, 10 and 20 wt. % Alcell lignin. 
 
4. NIR spectroscopy 
NIR spectroscopy was conducted to correlate the obtained spectra to the ribbon density obtained by 
roller compaction. The aim is to evaluate the applicability of NIR as a process analytical tool (PAT) 
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for development of continuous pharmaceutical manufacturing. The NIR spectroscopy has the ability 
to be used as on-line measurement tool of critical quality attributes of granules and ribbons such as 
density [21, 22, 24]. In order to evaluate the applicability of NIR for characterisation of various 
formulations and formulations containing lignin, the produced ribbons were characterised by a NIR 
probe to measure the envelope density. Off-line NIR spectroscopy was used by Multieye NIR 
instrument with the wavelength range of 1500-2200 nm and one probe to monitoring of Critical 
Quality Attributes. The NIR absorbance was found to be proportional to the envelope density of the 
ribbons. Partial Least Square (PLS) regression analysis was used for the calibration of the NIR results 
[22]. Cross validation analysis was conducted to calculate the numbers of principal components and 
the optimum number of components was obtained to be seven as shown in Figure 13. Utilising seven 
PLS components show more than 98 percent variance in ribbon density. However, considering higher 
PLS components may cause over-prediction, which is a major problem in estimation of ribbon 
density. Once the model has been built and calibrated, it can be used to measure the envelope density 
using the NIR spectra as inputs. The PLS regression results are shown in Fig. 14 where it can be 
concluded that the built PLS model is capable of calibrating the NIR spectrum to the density of the 















































Figure 14. Predicted versus measured ribbon density calculated by NIR. 
5. Conclusions 
The main objective of this study was to implement the quality-by-design approach to identify the 
correlation between critical process parameters (CPPs) and critical quality attributes (CQAs) of 
outputs from a dry granulation by roller compaction process. A variety of excipients with differing 
formulations were prepared and used in roll compaction process to produce ribbons and granules. 
Microcrystalline cellulose (MCC 102) was used as the base excipient, as it is a common widely used 
material in dry granulation process due to its inherent properties such as good compressibility because 
of fibrous structure and high capacity. Other formulations containing lactose and Alcell lignin were 
considered to understand the influence of formulation on the CQAs. 
The effects of CPPs including roll pressure and screw speed on the CQA, including ribbon density as 
well as D50 were investigated. The results indicated that a variation in roll pressure has a considerable 
effect on ribbon density and granules size (D50) in the roller compaction process. At higher roll 
pressure and constant screw speed, the amount of powder between rolls are constant and more 
pressure leads to more densification of powder, especially for smaller particle size, cohesive and 
compressible powders, and results in a higher density and larger D50 of granules size. On the other 
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of products, and it affects other process variables such as the amount of powders, roll gap, and 
residence time of powders between rolls. 
It was revealed that the properties and percentages of different excipients constrain the operability of 
the parameters used in roller compaction. However, as the process map is dependent on the 
formulation and equipment, generalisation of these process maps are needed based on dimensionless 
variables. The differences in mechanical properties of excipients leads to some differences in 
compaction behaviour during RC. Lactose shows higher compressibility than MCC 102 and Lignin. 
Therefore, lactose with smaller particle size, and larger surface area with increased particle contact 
tends to be more compressible than MCC 102, and can be used as modifier in the RC process. Also, 
lignin indicated almost similar behaviour with lactose, and can be a promising excipient in tablet 
manufacturing. 
Another important objective of this study was to investigate the capability of Alcell lignin as natural 
polymer to use as excipient to improve powder properties, costs and delivery of tablets as final 
products. Alcell lignin, as a natural polymer can improve granulation process because of good 
flowability, low cost and ease of availability. Interestingly, it was revealed that less operational 
limitations was observed when lignin was introduced as an excipient in the formulations. Moreover, 
the applicability of NIR spectroscopy as PAT tool for on-line measurement of ribbon density in roller 
compaction process was investigated and NIR has been shown to be robust and reliable enough to be 
used as an on-line measurement in the RC process for formulations containing lignin. 
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A.1. Flow function 
To measure the flowability of powders used in this study, the most commonly used parameter is flow 
function (FF) which is defined as [42, 43]: 
FF=MPS/UYS  (A.1) 
where MPS refers to the major principle stress acting on the powder, and UYS denotes the unconfined 
yield strength of the powder at the MPS. The values for MPS and UYS can be measured by shear cell 
test using FT4. The powders are categorised based on the FF values as listed in Table A.1. 
Table A 1. Classification of powders based on FF values. 
Type of flow Flow function (FF) 
Free flowing FF > 10 
Easy flowing 4<FF<10 
Cohesive 2<FF<4 
Very cohesive and non flowing FF<2 
 
A.2. Compressibility 
Compressibility is a measure of how density changes as a function of applied normal stress. Indeed, 
compressibility is the ability of powder to reduce in volume by applying stress. For powders, the bulk 
property is influenced by many factors such as particle size distribution, cohesivity, particle shape, 
and particle surface texture. The standard measurement method for compressibility of powders 
utilises a vented piston to compress the sample under increasing normal stress, and the compressibility 
is calculated using the following equation: 
Compressibility = percentage change in volume after compression (%)   (A.2) 
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As we mentioned in the manuscript, the compressibility was measured by FT4 powder rheometer. 
For powders, density is a function of applied normal stress. The changes in density of powders as a 
function of applied normal stress are known as compressibility [44]: 
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The compressibility of powders can be measured by using of Carr’s index and Hausner Ratio [45]: 
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The range of normal stress was between 1-2-4-6-8-10-12-15 kPa. 
The Basic Flowability Energy (BFE) value were measured by FT4 powder rheometer for the materials 
and the results showed that MCC 102 has the highest value of BFE = 177 (MJ), this value indicates 
that this material is free-flowing. On the other hand, BFE of lactose was the lowest BFE= 81.1 mj, it 
means lactose is more cohesive than other materials and for Alcell lignin BFE = 119 mj. 
A.3. Stability index 
Stability index is a simple analysis carried out to understand whether the formulation being analysed 
changes during the analysis. It is an indication of the stability of formulation during characterisation. 
The stability test runs the formulation through a series of identical measurements, and similar results 
would be obtained if the formulation being tested is stable. If the stability index is approximately 1, 
it means the powder is physically stable. The SI >1 or SI < 1 shows unstable powder. FT4 powder 
analyser uses the following stability index formula [46, 47]: 
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In the first chapter, powder and granule characterization have been done for different excipients and 
lignin as a new excipient. The results were shown lignin can be used as excipient in tablet formulation. 
As per our satisfactory results, we decided to use lignin as excipient to study the effect of that on drug 








































Effect of lignin as natural polymer on the release rate of acetylsalicylic acid 
tablets 
Mahboubeh Pishnamazi1, Javed Iqbal1, Saeed Shirazian1, Gavin M. Walker1, Maurice N. Collins2,3,* 
1 Department of Chemical Sciences, Bernal Institute, Synthesis and Solid State Pharmaceutical Centre 
(SSPC), University of Limerick, Limerick, Ireland 
2 Stokes Laboratories, Bernal Institute, University of Limerick, Limerick, Ireland 
3 Health Research Institute, University of Limerick, Limerick, Ireland. 
* Corresponding author, E-mail: maurice.collins@ul.ie 
 
Abstract 
The main focus here is on the improvement of formulations utilising non-conventional bio-based 
excipients to improve tablet release rates. Two different formulations were considered. The first 
formulation contains Alcell lignin, lactose monohydrate and microcrystalline cellulose as excipients 
and acetylsalicylic acid (aspirin) as active pharmaceutical ingredient (API). The second formulation 
contains lactose monohydrate and microcrystalline cellulose as excipients and aspirin as API. The 
prepared formulations were roller compacted followed by milling, sieving, and tableting. The tablets 
were then characterised in terms of dissolution rate in order to compare the release rates. Results 
indicated that tablets containing Alcell lignin have quicker release, faster disintegration times and 
higher tablet hardness for all samples with differing process parameters. Higher API dissolution has 
been attributed to the amorphous structure of lignin and its interaction with aspirin, which increases 
dissolution of the API. 

















Three different methods are considered for tablet manufacturing in the pharmaceutical industry, i.e. 
direct compaction, dry, and wet granulation. Recently, there has been focus on direct compaction due 
to cost and time effectiveness as less number of processing steps are involved. Moreover, the tablets 
produced by direct compaction have faster dissolution rates [1]. However, in order to improve powder 
flowability and bulk density, especially for poor flowing materials, granulation has proved useful. 
Dry granulation is continuous and is the preferred method for moisture and heat sensitive materials 
as no binder is used [2-6]. 
Today, one of the major challenges facing the pharmaceutical industry is to enhance the 
bioavailability which play a crucial role in drug development [7]. Tablet release rate has a significant 
effect on tablet bioavailability [8] in which higher release rates result in higher bioavailability and 
lower side effects. Currently, the most common method for enhancing the bioavailability of drugs is 
preparation of amorphous solid dispersion. In an amorphous solid dispersion (ASD), the API is 
transformed to amorphous phase from crystalline by various techniques, and then API is dispersed in 
a polymeric carrier, which enhances the dissolution of API molecules. 
Excipients are inert substances used in drug production to assist manufacturing and control the 
dosage, quality, stability, bioavailability, toxicity and efficacy [9-11]. For example, sugar compounds 
such as lactose and cellulose derivatives such as MCC are the most commonly used excipients in 
tablet manufacturing [10, 12, 13]. In this study, in order to investigate the effect of excipient on tablet 
release rate, disintegration and dissolution tests have been extensively studied [14-17]. Several 
researchers have illustrated that the influence of excipients on release of oral dosage drugs is 
significant [18-20]. The type of excipient, its physical and chemical properties, and interaction with 
API can effect processability and stability of tablets as well as overcome the drug side effects [21]. 
Therefore, tablet formulation can be considered as a critical factor in pharmaceutical production due 
to its considerable effect on disintegration, dissolution and drug release rate [7, 20, 22-24]. 
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Various researchers have focused on improved tablet release rate and drug absorption, etc. by 
developing novel excipients. Due to some issues in relation to side effects and release rates of solid 
dosage forms [25], use of materials with desired functionality as excipient in tablets are increasing. 
In tablet manufacturing, amorphous materials are showing great promise as excipients as they exhibit 
higher dissolution compared to crystalline equivalents due to disordered structure and higher free 
energy [25-29]. On the other hand, the thermodynamic instability of amorphous excipients used in 
tablets, might result in relaxation and crystal growth of crystalline API molecules over time which is 
not favourable for bioavailability [30]. 
Recently, biological macromolecules have attracted attention for use as excipient in tablet production 
to enhance drug dissolution and bioavailability. A number of studies have been carried out on lignin 
to improve chemical modification [31-33], and to develop new pharmaceutical formulations with 
increased functionality [34, 35] because of lignin structure which contains phenolic and aliphatic 
hydroxyl groups [35]. Lignin has a high potential to be used in tablet manufacturing either with 
chemical modification or without chemical modification [32]. Furthermore, some researchers have 
investigated the ability of lignin’s nanoparticles (NPs) in drug delivery due to its non-toxicity, 
biodegradability and stability. Lignin has also been used to transport hydrophobic drugs [36]. Lignin 
is an amorphous polymer and non-amphiphilic in nature, and displays high chemical stability due to 
3D network structure [37]. As lignin is rich in phenolic and aliphatic hydroxyl groups [38], it interacts 
with most API molecules through π-π stacking and hydrogen bonding, and this makes lignin 
potentially useful as a drug carrier to enhance bioavailability [39-42]. 
Aspirin, which is known as a delayed-release drug is utilised as a model API in this work [43, 44]. In 
fact, the dissolution rate of aspirin is the rate-limiting step, which controls the absorption and 
bioavailability. Moreover, another challenge associated with aspirin is that it hydrolyses to salicylic 
acid upon exposure to aqueous solutions, which should be taken into account during the dissolution 
tests [8, 15, 41, 45-47]. Wang et al. have investigated aspirin hydrolysis during dissolution tests, and 
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found out that the hydrolysis of aspirin occurs during dissolution [47]. Sumirtapura et al. studied the 
dissolution of different types of acetylsalicylic acid products, and distinguished time lags for differing 
aspirin tablets [46]. Peltonen et al. utilised three different tablets containing aspirin for dissolution 
tests. The first type of tablets contained aspirin and MCC; the second ones consisted of aspirin and 
lactose, while the third ones included aspirin, lactose and MCC. They investigated the effect of pH 
on aspirin release rate and found higher release at higher pH. Moreover, they reported that adding 
lactose to aspirin in the formulation leads to increased release rate. On the other hand, adding MCC 
results in decreased release rate [15]. 
In comparison with other literature, the authors have tried to analyse the dissolution of different 
formulations containing aspirin as API and various excipients. Lignin was used as a new excipient to 
evaluate its performance in tablet manufacturing in order to improve drug release rates. Indeed, the 
purpose of this study is to investigate the effect of Alcell lignin on tablet properties including 
hardness, disintegration time and drug release rate. The main aim is to explore the possibility of using 
lignin as natural material to enhance bioavailability of poorly water-soluble drugs. Two different 
formulations are utilised, one formulation containing Alcell lignin and another one without lignin. 
First, two different blends are roller compacted to produce ribbons. Then, the produced ribbons are 
milled to make granules. Afterwards, these granules are used to produce tablets. Different tablet 
characterisation tests including; disintegration, hardness and dissolution tests are carried out to 
understand the effect of lignin as natural polymer on drug release rate. 
2. Experimental procedure 
2.1. Materials and methods 
In order to prepare the formulations, acetylsalicylic acid (Alfa Aesar, 99% C9H8O4) was utilised as a 
model API. Different excipients were utilised including microcrystalline cellulose (MCC SANAQ® 
102 L USP/NF/EP), lactose monohydrate (Lennox USP, NF, BP, Ph, pure pharma grade) and Alcell 
lignin (Tecnaro (Ilsfeld, Germany)). More details on the lignin used in this study can be found 
elsewhere [33, 48]. To prepare the mixtures, 1% w/w magnesium stearate (Sigma-Aldrich, Ph. Eur., 
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BP, ≥90% stearic and palmitic acid basis), as lubricant and croscarmellose sodium (CCS) (IMCD NF, 
PH.Eur.,JP) as disintegrant were used in the formulations. Table 1 illustrates the two different 
formulations considered; in the first one; 5 wt. % of aspirin was mixed with 20 wt. % of lactose, 20 
wt. % of lignin, 3 wt. % of CCS and 1 wt. % MgSt, and the rest is MCC 102. The second formulation 
was prepared with 5 wt. % of aspirin, 20 wt. % of lactose, 3 wt. % of CCS, 1 wt. % MgSt, and the 
rest is MCC 102. All components were mixed using a Morphy Richards Stand Mixer. Ortho-
phosphoric acid (analytical reagent grade, Fisher Scientific UK) and acetonitrile, HPLC grade, 
99.7+% min Liquid (Alfa Aesar) were mixed to prepare mobile phase for HPLC analysis. 






2.2. Equipment and instruments 
2.2.1 Dry granulation by roll compaction and milling process 
To prepare the tablets, the dry granulation method was used for the entirety of this work in a series 
of ribbon production, milling, and tabletting. The ribbons were produced using a roller compactor 
(Freund TF-MINI, Vector Corporation, Japan) integrated with a vertical screw feeder for feeding the 
formulations. The rollers dimensions are 100 mm in diameter and 25 mm in width. The considered 
process parameters included screw speed (SS) and roll pressure (RP), while roll speed was kept 
constant at 4 rpm. The screw speed was changed between 10-14 rpm, and roll pressure was changed 
between 30-50 bars in the ribbon production experiments. The density of produced ribbons were 
measured using GeoPyc density analyser (GeoPyc 1360, Micrometrics Instrument Corp. 4356 
communications Drive, Norcross, GA 30093, USA). The produced ribbons were then milled using a 
Material A B 
Acetylsalicylic acid (% wt.) 5 5 
Alcell lignin (% wt.) 20 0 
Lactose (% wt.) 20 20 
MCC 102 (% wt.) 51 71 
Croscarmellose sodium (% wt.) 3 3 
Magnesium stearate (% wt.) 1 1 
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conical mill (Laboratory Comil 193 AS, Quadro, USA) with mesh size of 813 µm, and impeller speed 
of 3000 rpm. The particle size distribution (PSD) of fine powder and granules were measured using 
Microtrac S3500 particle size analyser (Malvern, USA). 
2.2.2 Tablet preparation and characterisation 
A benchtop single punch tablet press (Gamlen Tableting GTD-1 D series, UK) was used to produce 
the tablets with different formulations. 100 mg of two different formulations of produced granules 
were pressed to make tablets in a 6 mm (diameter) die. The tablet compression was carried out at 180 
mm/min speed under fixed load of 400 kg. Croscarmellose sodium was used as super disintegrant in 
tablet preparation experiments [23]. 
Hardness of the produced tablets was measured using a tablet hardness tester (Pharma Test, PTB 
311E 3 in 1 hardness, diameter and thickness tester, Hainburg, Germany).. To measure the 
disintegration time, Pharma Test PTZ-DIST- Disintegration Test Instrument (Hainburg, Germany) 
was used. The apparatus chamber was filled with 900 mL of deionized water and the apparatus paddle 
was adjusted at 100 rpm. Three samples were tested in deionized water at 37 ̊ C for each process 
parameters and for two different formulations. All the disintegration tests were conducted until the 
tablets completely disintegrate. The dissolution of produced tablets was performed using a Pharma 
Test PTWS 120D 6-Station Tablet Dissolution Testing Instrument (Hainburg, Germany). 
The concentration of the API in each sample was measured using High Performance Liquid 
Chromatography (HPLC). Chromatography was performed using an Agilent Technologies 
(Waldbron, Germany) 1260 Infinity II HPLC system. The HPLC system consisted of a quaternary 
pump G1311B, a diode array detector G1315D set at wavelengths of 200 nm for acetylsalicylic acid 
and salicylic acid, auto-sampler G1329 B and a thermostated column compartment G1316A set at 25 
°C. The system operated under isocratic flow at 0.75 mL/min using mobile phases consisting of A) 
0.1 % Ortho-phosphoric acid; B) acetonitrile; A/B =50/50, v/v. The injection volume was 10 mL. The 
total run time was 10 minutes, and the type of column used was Kromasil 5C18 (250×4.6 mm). 
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2.3. Dissolution test procedure 
The dissolution chamber was filled with 500 mL of prepared medium 0.1 N HCl (ACS, ISO, Reag. 
Ph Eur, Hydrochloric acid fuming 37% wt.) at pH=1.2. The medium temperature was kept constant 
at 37 ± 0.5 ̊ C and the stirrer was adjusted to a speed of 75 rpm [45]. When the temperature reached 
37 ̊ C, one tablet was placed in each dissolution vessel to run the dissolution test for 120 minutes. 
Three mL of the dissolution medium were withdrawn at 5, 10, 20, 30, 40, 50, 60 and 120 minutes, 
then medium was replaced with the same amount, immediately. Then, the samples were filtered using 
Captiva Econofilters (PTFE membrane, 13 mm diameter, 0.2-µm pore size) syringes to prepare for 
the analysis by HPLC at 200 nm wavelength, immediately, due to hydrolysis of acetylsalicylic acid. 
 In order to prepare the buffer solution (pH = 1.2) for the dissolution tests, 2 g sodium chloride was 
dissolved in 200 mL deionized water. Then, it was diluted with deionized water in a 1000 mL 
volumetric flask and 7 mL HCl was added. In order to prepare the calibration solutions for HPLC 
analysis, 5 mg of acetylsalicylic acid and 5 mg salicylic acid were dissolved in 20 mL of buffer 
solution, separately. Then, they were mixed to prepare the calibration solution. Afterwards, the 
prepared solutions were diluted with buffer solution 6 times. The standard curves of drug 
concentration vs peak area were drawn for different formulations giving R2= 0.99. 
3. Results and discussion 
3.1. Dissolution profiles for two different formulations 
Two different formulations were evaluated to find the effect of Alcell lignin on the aspirin tablet 
release rate. One formulation contains Alcell lignin, MCC 102 and lactose as excipients and the other 
one contains lactose and MCC 102 as excipients. Both formulations contain aspirin as API. Fig. 1 
illustrates the graphs of drug release rate for tablets prepared at various process parameters. As seen, 
different levels of screw speed and roll pressure were considered in this study. Interestingly, the 
results show that the tablets containing Alcell lignin have higher release rate than the tablets without 
lignin for all prepared samples. In addition, the equilibrium dissolution for the tablets containing 
lignin is greater which is attributed to the enhancement of solubility of ASA with addition of lignin. 
It is also seen that faster release kinetics is obtained for the tablets containing lignin such that the 
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majority of the API are dissolved in the first 10 minutes of the dissolution test. Moreover, the tablets 
prepared with lignin indicated less variability in the dissolution measurements. The data is provided 
in the Supplementary file for both formulations. 
In other words, tablets containing lignin with very high release rate acts as a disintegrating agent in 
the dissolution chamber, facilitate the dissolution kinetics, and accelerate to equilibrium release. 
Moreover, due to amorphous nature of lignin, it may be concluded that lignin enhances the solubility 
of API due to its disordered structure and higher Gibbs free energy of the amorphous phase in the 
dissolution media. The cross-linked structure of lignin is likely to have an effect on dissolution and 
disintegration as well. Peltonen et al. [15] studied the effect of pH on the release rate of aspirin tablets 
with different formulations (B (aspirin & lactose), A (aspirin, lactose &MCC) and C (aspirin 
&MCC)). They illustrated in pH 1.2 the release rate of aspirin with the different formulations are low 
and it does not show 100% release rate after  more than 200 minutes. Maximum release rates of the 
formulation B was around 90% after 200 minutes. For formulation A, the release rate was around 
80% after 500 minutes and for formulation C was around 70% after 500 minutes. 
The roll compaction process parameters affect the release rate of aspirin also in which the effect of 
roll pressure is more significant compared to screw speed. For the tablets without lignin, increasing 
roll pressure (at constant screw speed of 14 rpm) results in reduction of API dissolution, which could 
be attributed to the particle size of granules, which produce the tablets. In the roll compaction process, 
increasing the roll pressure results in enhancement of granule size. However, the effect of process 
parameters on the API dissolution is not significant, because the dissolution depends mainly on the 
chemical structure of API and interaction with the dissolution medium. In fact, the granulation 













































































































































Figure 1. Dissolution release rate of acetylsalicylic acid for different lignin and non-lignin tablets at 
different process parameters. 
 
3.2. Effect of process parameters on tablet disintegration time 
The effect of roll pressure and screw speed as the main process parameters of dry granulation on the 
tablet disintegration time for the two formulations is shown in Fig. 2. In terms of the effect of roll 
pressure as process parameter on disintegration time of tablets, the results illustrate that increasing 
the roll pressure while keeping the screw speed constant, results in decreasing the disintegration time 
for both formulations. Increasing the roll pressure results in higher densify of ribbons during the roll 
compaction process, and subsequently produce larger granules because higher mechanical energy is 
required to break up the ribbons during the milling step. The tablets made with larger granules will 
be more porous, and subsequently leads to faster disintegration time. It is also observed from Fig. 2 
that the tablets containing lignin have faster disintegration time than non-lignin tablets due to the 
amorphous and inherent structure of lignin, which has higher affinity towards the solution media 
compared to MCC and lactose. 
Moreover, the particle size of raw materials used as excipients are shown in Fig. 3. As observed, 
lignin has smaller particle size compared to MCC 102, and introducing lignin as an excipient results 




























during the roll compaction and denser ribbons are produced, which in turn results in larger granules 
in the milling stage [49]. Furthermore, the size distributions of the used granules for tableting are 
shown in the Supplementary file. It is seen that the formulation containing lignin has slightly larger 







































































Figure 2. Disintegration time of tablets prepared with and without lignin as function of process 
parameters. 
 
Figure 3. Particle size distribution of materials; MCC 102, lactose and lignin. 
 
3.3. Effect of process parameters on tablet hardness 
Fig. 4 illustrates the hardness of the tablets prepared using the two formulations as a function of 
process parameters. The results reveal that the lignin tablets have higher hardness than non-lignin 





















































hardness due to larger granules being obtained at higher roll pressure which in turn leads to weak 
physical bonds between particles. The results also indicate that by increasing screw speed, the tablet 
hardness decreases; however, the change is not considerable. In addition, the standard range of tablet 
hardness is between 39-79 N, therefore the lignin tablets are within the standard range of hardness. 
The reason why tablets containing lignin display higher hardness can be attributed to the interaction 
between lignin and other constituents of the formulation where lignin acts as a binder thereby 
increasing tablet hardness. 
  
  
































































































































The main aim of this study was to investigate the effect of lignin-based excipients on release of oral 
dosage aspirin tablets. Lignin was selected as an excipient to evaluate its influence on release rate and 
tablet properties at varying processing conditions due its chemical structure. Results illustrated that 
lignin tablets compared to non-lignin tablets have higher hardness, faster disintegration time, and 
higher release rate. Indeed, the critical quality attributes of the tablets were improved by introducing 
the lignin. Higher release rate of tablets with lignin formulation are due to amorphous structure of 
lignin and interaction with the API, which improves drug solubility and therefore bioavailability, the 
key factor in oral dosage development. On the other hand, higher roll pressure leads to more densified 
ribbons associated with lignin blends and consequently, larger granules are produced. These larger 
granules result in porous tablets, which leads to faster disintegration times as solute diffuses faster 
into the tablets. Also, the greater hardness for the tablets containing lignin are attributed to better 
affinity between lignin and MCC which leads to lignin acting as a tablet binder. 
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1. Granule size distribution 

















































































































































2. Statistical analysis and Error bars 
The variability of tablet dissolution tests are shown in Figure S2 as the error bar for lignin formulation 







Figure S2: Variability of dissolution tests for formulations containing lignin and without lignin at 





































































































































































































































Figure S4. Error bars of tablet disintegration times for lignin tablet and non-lignin tablet at different 
process parameters 
3. T-Test Analysis data 
"An independent samples t- test was conducted to compare the means of "non-lignin tablet and lignin 
tablet” for 14 rpm screw speed. There was a significant difference between the mean of "1st variable", 
non-lignin tablet (mean=68.0034289, sd=5.07354) and "2nd variable", lignin tablet 
(mean=84.6754382, sd=7.27744) with t=-9.21 and p < 0.001". 
 
"An independent samples t- test was conducted to compare the means of "non-lignin tablet and lignin 
tablet” for 12 rpm screw speed. There was a significant difference between the mean of "1st variable", 
non-lignin tablet (mean=71.71319637, sd=6.5463992) and "2nd variable", lignin tablet 













































Table 2. T-Test 
t-Test: Two-Sample Assuming Equal Variances     
 Non-lignin tablet/ Lignin tablet -14rpm screw speed   Variable 1  Variable 2 
  Non-lignin tablet Lignin tablet 
Mean 68.0034289 84.6754382 
Variance 25.7408246 52.9611617 
Observations 24 24 
Pooled Variance 39.3509932   
Hypothesized Mean Difference 0   
df 46   
t Stat -9.20663055   
P(T<=t) one-tail 2.6356E-12   
t Critical one-tail 1.67866041   
P(T<=t) two-tail 5.2712E-12   
t Critical two-tail 2.0128956   
 
Table 3. T-Test 
t-Test: Two-Sample Assuming Equal Variances     
Non-lignin tablet/ Lignin tablet -12 rpm screw speed  Variable 1  Variable 2 
  Non-lignin tablet Lignin tablet 
Mean 71.71319637 82.92867437 
Variance 42.85534259 73.7575801 
Observations 24 24 
Pooled Variance 58.30646134   
Hypothesized Mean Difference 0   
df 46   
t Stat -5.088034748   
P(T<=t) one-tail 3.269E-06   
t Critical one-tail 1.678660414   
P(T<=t) two-tail 6.538E-06   












In chapter 2, the results are shown lignin is a good candidate to use as excipient in tablet formulation. 
The results showed higher drug release rate for the formulation containing lignin, which was 
interesting. Then, we decided to model the drug release rate using Artificial Neural Network (ANN) 
and MATLAB to study the applicability of ANN modelling for drug release rate, which could be very 
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Abstract 
Predictive models for simulation of drug release from tablets containing lignin as excipient were 
developed in this work. Two predictive models including Artificial Neural Network (ANN) and 
hybrid ANN-Kriging were developed to simulate the tablet dissolution. Measured data was collected 
on the release rate of aspirin tablets prepared by dry granulation via roll compaction followed by 
milling and tableting. Two formulations were considered, one with lignin and one without. The main 
aim is to show the effect of lignin as a bio-based natural polymer in tablet manufacturing to control 
drug dissolution. For the ANN model development, process and formulation parameters including 
roll pressure and lignin content were considered as the input, while API dissolution was considered 
as response. The predictions were compared with measured data to calibrate and validate the model. 
To improve the predictability of the model, Kriging interpolation was used to enhance the number of 
training points for the ANN. The interpolated data was trained and validated. The final concentration 
and the dissolution rate were predicted by ANN as well as ANN-Kriging models, and the R2 of greater 
than 0.99 for most cases was obtained. The validated model was used to evaluate the effect of process 
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parameters on the release rate and it was indicated that the tablets containing lignin have higher 
release rate compared to tablets without. Also, it was revealed that process parameters do not have 
significant effect on the tablet release rate, and the tablet release rate is mainly affected by the lignin 
content. The results indicated that ANN-based model is a powerful tool to predict the API release rate 
for tablets containing various formulations, and can be used as a predictive tool for design of 
controlled release systems. 
 
Keywords: ANN model; Kriging interpolation; Controlled release; Lignin; Pharmaceuticals; 




















Most drugs are administered in solid phase, such as crystalline particles which are processed into 
tablets or capsules by adding excipients (Siepmann and Siepmann, 2013). In pharmaceutical 
manufacturing of solid-dosage oral formulations, there are different unit operations such as blending, 
granulation, drying, tableting, and coating among which granulation is the key processing step as the 
tablet properties depend on the granules attributes such as size, API content, porosity, etc. (Hansuld 
and Briens, 2014; Shirazian et al., 2018; Suresh et al., 2017; Vervaet and Remon, 2005). In 
granulation processes, pharmaceutical granules are formed from fine powder (e.g. excipient and API) 
using various methods such as roller compaction, high-shear wet granulation, twin-screw granulation, 
fluidised bed granulation, and hot melt extrusion (Asada et al., 2018; Hansuld and Briens, 2014; Ko 
et al., 2018; Passerini et al., 2010; Walker et al., 2007). The main reason for granulation is to improve 
the powder flowability as well as tablet properties. Among various granulation processes developed 
so far, dry granulation is a suitable process for moisture and heat sensitive formulations, as no binder 
is used in the process. Dry granulation is usually carried out using roller compaction process in which 
the formulation is first compacted to produce ribbons, and then granules are produced by milling the 
ribbons. The critical process parameters in roller compaction process include roll pressure, roll speed, 
roll gap, and screw feeder speed (Al-Asady et al., 2015; Omar et al., 2016). 
Understanding the relationship between process parameters of the roll compaction process and tablet 
properties is of great importance for development of pharmaceutical manufacturing and 
implementing Quality-by-Design (QbD) approach. The effect of process parameters and material 
properties on critical quality attributes of ribbons and granules have been reported in literature. Both 
experimental (Khorasani et al., 2016; Khorasani et al., 2015) and theoretical studies (Loreti et al., 
2017; Pérez Gago et al., 2016; Reynolds et al., 2010; Souihi et al., 2015) have been conducted to 
understand the roller compaction process. In terms of modelling studies, Johanson has proven to be 
a robust and rigorous mechanistic model for better understanding of roller compaction process 
(Reynolds et al., 2010). Although, previous studies reveal the correlation between critical process 
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parameters and granules/ribbons properties in roller compaction processes (Pishnamazi et al., 2018), 
understanding the relationship between process parameters and tablet dissolution still remains a 
challenge and opportunities arise in helping to improve tablet dissolution rate by tuning formulation 
and process parameters. 
Drug dissolution is an important quality attribute of pharmaceutical tablets in which the kinetics and 
equilibrium concentration (solubility) of Active Pharmaceutical Ingredient (API) release from the 
tablets is of utmost importance (Siepmann and Siepmann, 2013). The main focus of controlled release 
systems is to manipulate the release rate of APIs through different techniques such as incorporating 
into polymeric matrix (Castro-Dominguez et al., 2017), and loading drug in stimuli-responsive 
nanocarriers (Fleige et al., 2012), and therefore enhancing bioavailability for poorly water soluble 
APIs. Nowadays, a big challenge facing the pharma industry is poor solubility of newly produced 
drugs in the body, i.e. bioavailability (Savjani et al., 2012). According to Biopharmaceutics 
Classification System, BCS Class II and BCS Class IV many drugs are of poor solubility and 
bioavailability (Daousani and Macheras, 2016). It has been recognised that seven out of ten of drugs 
never reach the patients. Development of solid dispersions have been reported to be effective in 
improving the solubility of BCS Class II drugs (Van den Mooter, 2012). Amorphous solid dispersions 
provide high dissolution rates because of their disordered structure and higher Gibbs free energy 
compared to crystalline APIs (Ziaee et al., 2017). 
Recently, lignin has attracted much attention as it may be used to improve the release of bio-active 
compounds (Chowdhury, 2014; Collins et al., 2019). Lignin is a cross-linked natural polymer, cheap, 
and available (Culebras et al., 2018). Due to amorphous nature of lignin which has higher free energy, 
it can be used as modifier to enhance the bioavailability of poorly soluble APIs. However, 
understanding the effect of lignin on dry granulation using roller compactor, and finding a correlation 
between lignin content and tablet dissolution rate remains a big challenge. Developing a robust 
predictive model for designing controlled release systems based on natural polymers is of great 
importance for pharmaceutical industry. 
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Therefore, there is a definite need for a comprehensive study to correlate the critical process 
parameters of roller compactor as well as formulation with tablet dissolution as the key critical quality 
attribute. A powerful tool is the development of a process model where inputs and outputs can be 
correlated. Different models have been used for pharmaceutical manufacture such as mechanistic 
models (Sajjia et al., 2017; Shirazian et al., 2018) and soft computing approaches (Mustafa et al., 
2017; Shirazian et al., 2017). Artificial Neural Network (ANN) is a soft computing method which is 
capable of predicting the process and making correlation between process inputs and outputs (Ismail 
et al., 2019a; Ismail et al., 2019b). Applicability, robustness, and reliability of ANN in 
pharmaceuticals have been verified in the literature (Das and Chakraborty, 2016; Mustafa et al., 2017; 
Shirazian et al., 2017). 
The main objective of the current study is the development of a comprehensive ANN-based model 
for prediction of dissolution rate of tablets prepared by roller compaction followed by milling and 
tableting. In order to enhance the bioavailability of API, lignin is used as excipient and the tablet 
dissolution rate is measured for tablets containing lignin and without lignin. Aspirin is used as model 
API in this study. 
2. Experiments 
2.1. Materials and Methods 
Two formulations containing API and excipients were considered in this study for preparation of 
tablets. The excipients used include microcrystalline cellulose (MCC 102, SANAQ®), lactose 
monohydrate (Lennox USP, NF, BP, Ph, pure pharma grade), and Alcell lignin (Tecnaro, Germany). 
More details on the lignin used in this study can be found elsewhere (Culebras et al., 2018). 
Acetylsalicylic acid (Alfa Aesar, 99% C9H8O4) was utilised as API in both formulations. Magnesium 
stearate (Sigma-Aldrich, Ph. Eur., BP, ≥90%) was used as lubricant for the compaction experiments, 
and Croscarmellose sodium (CCS) (IMCD NF, PH.Eur., JP) was used as disintegrant in both 
formulations. The percentage of the materials used in two different formulations are listed in Table 
1. To prepare the mixture, all the materials were blended using a Morphy Richards Stand Mixer. HCl 
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acid (ACS, ISO, Reag. Ph Eur, Hydrochloric acid fuming 37%) was used for preparation of buffer 
solutions for dissolution tests. For preparation of the mobile phase for analysing the API concentration 
with HPLC, Ortho-phosphoric acid (analytical reagent grade, Fisher Scientific UK) and acetonitrile, 
HPLC grade, 99.7+% min Liquid (Alfa Aesar) were mixed together. 







2.2. Equipment and instruments 
Dry granulation method was utilised to produce the tablets for two different formulations. In order to 
do dry granulation process, roller compaction was carried out. The roller compactor, Freund TF-MINI 
(Vector Corporation, Japan) with roll diameter of 100 mm and width of 25 mm integrated with a 
vertical screw feeder was used to produce ribbons. The roll pressure was changed between 30 and 50 
bar in the experiments. A conical mill (Laboratory Comil 193 AS, Quadro, USA) with a screen (mesh 
size of 813 µm) and impeller speed of 3000 rpm was used to produce the granules from the ribbons. 
The considered process parameters included screw speed (SS) and roll pressure (RP), while roll speed 
was kept constant at 4 rpm. The screw speed was changed between 10-14 rpm, and roll pressure was 
changed between 30-50 bars in the ribbon production experiments. 
For tableting process, a single punch tablet press (Gamlen Tableting GTD-1 D series, UK) was 
applied. For preparation of each tablet, 100 mg of granules of each formulations were measured and 
compacted to produce tablets in a 6 mm die. The tablet compression was carried out at 180 mm/min 
speed under fixed load of 400 kg. 
Material (% w/w) Formulation 1 Formulation 2 
Acetylsalicylic acid 5 5 
Alcell lignin 20 0 
Lactose 20 20 
MCC 102 51 71 
Croscarmellose sodium 3 3 
Magnesium stearate 1 1 
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2.3. Dissolution procedure 
For the dissolution analysis, buffer solution at pH= 1.2, including 0.1 N HCl (ACS, ISO, Reag. Ph 
Eur, Hydrochloric acid fuming 37% wt.) was prepared as dissolution medium. 500 ml of the 
dissolution test chamber was filled with the buffer solution, with the constant temperature at 37 ± 0.5 ̊ 
C and 75 rpm stirrer speed. The experiment was run for 120 minutes, and the samples (Three mL) 
were withdrawn from the dissolution chamber at 5, 10, 20, 30, 40, 50, 60, 120 minutes. Afterward, 
the samples were filtered and the concentration of API was measured using HPLC at wavelength of 
200 nm. The dissolution tests were carried out in triplicate, and the average values were used for 
modeling. 
High-Performance Liquid Chromatography (HPLC) was used to measure the API concentration in 
each samples via an Agilent (Agilent Technologies, Waldbronn, Germany) 1260 Infinity II HPLC 
system. The HPLC setup consisted of a quaternary pump G1311B, a diode array detector G1315D 
set at wavelengths of 200 nm for acetylsalicylic acid, auto-sampler G1329 B and a thermostated 
column compartment G1316A set at temperature of 25 °C. The system operated under isocratic flow 
at 0.75 mL/min using mobile phases consisting of A) 0.1 % Ortho-phosphoric acid; B) acetonitrile; 
A/B =50/50, v/v. The injection volume was 10 mL. The total run time was 10 minutes, and the type 
of column used was Kromasil 5C18 (250×4.6 mm) (Pishnamazi et al., 2019). 
3. Model development 
3.1. ANN structure 
In order to develop a predictive model, artificial neural network (ANN) approach was used in which 
the process parameters and material properties are correlated with critical quality attributes. Roll 
pressure, screw speed, and lignin content in the formulation were considered as the inputs, whereas 
the kinetics and final API dissolution were considered as outputs for developing ANN. The 
preliminary results indicated that screw speed has negligible effects on the quality attributes of 
ribbons, therefore, screw speed was omitted from the process parameters. An ANN model consisting 
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of two hidden layers was developed as shown in Fig. 1. JMP Pro 14 software was used for developing 
the ANN model and analysing the results. 
 
Figure 1. Structure of developed ANN for prediction of drug release. 
 
To find the optimum ANN structure, different transfer functions were tested, and the best results were 
obtained for the structure consisting of 6 non-liner (hyperbolic tangent), 2 liners, and 2 Gaussian 
functions in the first layer; with 6 non-linear nodes for the second layer (see Fig. 1). In ANN 
modelling using JMP, the linear combination of input variables (roll pressure and lignin content) are 
not transformed when using the linear activation function, while for the non-linear function, the 
hyperbolic tangent term is used as follows (SAS_Institute, 2016; Shirazian et al., 2017): 
DE F 1DE G 1 (1) 
where z is a linear combination of input variables. 
In order to build ANN model, 60 % of the measured data was used to train the network, while 40% 
was used for model validation and testing the developed model in prediction of the API release rate. 
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The network was trained to predict the concentration of API at different sampling time intervals, as 
function of lignin content and roll pressure of roller compactor. The developed ANN model was used 
for prediction of API release rate, in which the predictive behaviour and accuracy of the model is 
assessed by comparing the predicted values and the measured values. The coefficient of determination 
(R2) which indicates the goodness of fitting is calculated as (Barrasso et al., 2015; Shirazian et al., 
2017): 
HD = 1 − ∑ 7J − :D∑ 7K − :D  
(2) 
where f refers to the predicted points, and y refers to the observed values. i denotes the set of 
experimental run. Also, root-mean-squared error (RMSE) is calculated as: 
RMSE = P∑ 7J − :D   
(3) 
where n denotes the number of measurements. 
3.2. ANN-Kriging hybrid model 
In order to improve the predictability of the developed ANN model for API dissolution, Kriging 
interpolation method was used to enhance the number of training and validating points for the ANN. 
Ordinary Kriging interpolation was developed based on two inputs and eight outputs which are the 
dissolution percentage at various times. Kriging method predicts a response yk at an interpolated point 
xk as a weighted sum of the observed responses (y1,y2…yn) where xk falls in the neighbourhood of 
their corresponding sampling points (x1,x2,x3…xn) (Boukouvala et al., 2011):  
0 = J7+0: = 	∑ QJ7+:RS                                                      (4) 
Q is the weighted sum (kriging weights) which depends on the Euclidian distance ℎ: 
ℎ = 	U+ − +VU                                                                            (5) 
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In Kriging algorithm, the main objective is to calculate the set of Kriging weights assigned to each 
group of n clustered points in the neighbourhood of +0 where the derived variogram model leads the 
sum of the weights to unity. In calculating the interpolated prediction J7+0: at +0, the observed 
responses (y1,y2…yn) for sampled points (x1,x2,x3…xn) that are in the neighbourhood and nearer to 
+0 will have more influence on predicting J7+0:. Indeed, the higher number of neighbouring points 
and the nearer these neighbouring points are to +0, J7+0: will be calculated with more confidence 
(Ismail et al., 2019a; Ismail et al., 2019b). 
In ordinary kriging interpolation, the experimental variogram is calculated from the experimental data 
points to statistically quantify the dataset in a form that fits statistical equations (exponential, 
Gaussian, cubic…etc.). After fitting the experimental and theoretical variograms, kriging weights are 
then calculated to determine the interpolated response. 
A two-dimensional kriging interpolation was conducted on the experimental data obtained from the 
dissolution experiments to predict the dissolution of API at new data points. The reliability and 
validity of the hybrid ANN-kriging has been proved in our previous works (Ismail et al., 2019a; Ismail 
et al., 2019b). Ordinary Kriging interpolation was performed in Matlab where the lignin content (%) 
and roller pressure (bar) were taken as input parameters and API dissolution at 5, 10, 20, 30, 40, 50, 
60 and 120 minutes as output parameters. Interpolation was conducted at 10 new points for each 
dimension in which 121 points were obtained after applying Kriging. The interpolated kriging data 
was used to improve the empirical ANN model prediction compared to using just experimental data. 
The structure of the developed ANN-Kriging is shown in Fig. 2. As seen, the hybrid model contains 
two hidden layers, each layer constitutes of three nodes which makes the model simpler and faster to 
solve. Also, a combination of linear and nonlinear transfer functions has been used for the hybrid 




Figure 2. Structure of developed ANN-Kriging hybrid model for prediction of drug release. 
 
4. Results and discussion 
4.1. ANN model 
The developed ANN model was first trained using the experimental data collected on the release rate 
of tablets containing aspirin. The trained network was then used to validate the model. The results of 
training and validation are listed in Table 2 for the concentration of API at different times, and the 
final concentration of API at the time of 120 minutes (final). As seen, the model is very well trained 
with the experimental data, and the R2 of 1 is obtained for all points, while for the validation R2 of 
0.99 is obtained for most cases except for predicting the concentration of API after 5 minutes which 
could be attributed to high release rate at the beginning of the dissolution test. It is clearly observed 
that the model can predict the release rate of API with high accuracy, and can be used as a powerful 
predictive tool for the design of release systems based on lignin. However, it should be pointed out 
that there might be a risk of over-prediction in this system as small number of experimental points 
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are used. Therefore, Kriging approach was used to train the network for more data points and prevent 
the risk of over-prediction. 
Table 2. Statistical data of ANN calibration and validation. 
times Data set R2 RMSE Mean Abs Dev -Log Likelihood SSE Data points 
5 min Training 1 8.7e-13 7.5e-13 -105.4 3.0e-24 4 
Validation 0.52 2.6 1.9 4.8 14.0 2 
10 min Training 1 2.1e-13 1.8e-13 -110.9 1.9e-25 4 
Validation 0.99 0.2 0.2 -0.2 0.1 2 
20 min Training 1 3.7e-13 3.2e-13 -108.8 5.6e-25 4 
Validation 0.99 0.5 0.4 1.5 0.5 2 
30 min Training 1 4.3e-13 3.7e-13 -108.2 7.3e-25 4 
Validation 0.99 0.6 0.6 1.7 0.6 2 
40 min Training 1 4.3e-13 3.7e-13 -108.2 7.5e-25 4 
Validation 0.99 0.4 0.4 1.1 0.4 2 
50 min Training 1 2.9e-13 2.4e-13 -109.8 3.3e-25 4 
Validation 0.91 1.5 1.4 3.7 4.7 2 
60 min Training 1 4.1e-13 3.5e-13 -108.4 6.7e-25 4 
Validation 0.99 0.1 0.1 -0.9 0.04 2 
120 min Training 1 4.0e-13 3.3e-13 -108.5 6.4e-25 4 
Validation 0.99 0.3 0.3 0.6 0.2 2 
 
4.2. ANN-Kriging model 
The predicted release rate versus the measured values for both training and validation for the hybrid 
ANN-Kriging model are depicted in Fig. 3. Moreover, the statistical data of the calibration and 
validation for the hybrid ANN-Kriging is listed in Table 3. After Kriging, the number of data points 
are increased to 121 points to make a more robust predictive model. 1/3 of the data points were used 
for validation, while 2/3 were used for training the network. It is clearly seen that the model is well 
trained for all the training points and the cross validation can confirm the model can be used for 
prediction of the dissolution. Also, similar to the ANN model, some deviations are observed for the 
dissolution data after 5 minutes, however R2 has been significantly improved for 5 minutes data from 










































































Figure 3. Actual versus predicted values of drug release for the hybrid ANN-Kriging model. A: 5 mins, 




Table 3: Statistical data of hybrid ANN-Kriging calibration and validation. 
times Data set R2 RMSE Mean Abs Dev -Log Likelihood SSE Data points 
5 min Training 0.69 0.98 0.68 135.83 93.45 97 
Validation 0.67 0.89 0.71 31.15 18.84 24 
10 min Training 0.99 0.34 0.27 32.50 11.10 97 
Validation 0.99 0.30 0.26 5.54 2.23 24 
20 min Training 0.99 0.13 0.09 -60.92 1.62 97 
Validation 0.99 0.14 0.10 -12.88 0.48 24 
30 min Training 0.99 0.07 0.05 -113.76 0.54 97 
Validation 0.99 0.07 0.06 -27.58 0.14 24 
40 min Training 0.99 0.07 0.057 -116.05 0.52 97 
Validation 0.99 0.07 0.05 -27.56 0.14 24 
50 min Training 0.99 0.10 0.07 -83.30 1.02 97 
Validation 0.99 0.12 0.08 -16.13 0.36 24 
60 min Training 0.99 0.06 0.05 -133.06 0.36 97 
Validation 0.99 0.06 0.05 -31.47 0.10 24 
120 min Training 0.99 0.07 0.05 -120.85 0.47 97 
Validation 0.99 0.07 0.05 -29.28 0.12 24 
 
4.3. Simulation of the release rate using ANN model 
The validated model was used to simulate the release rate of API for the tablets prepared with two 
formulations. The experimental and predicted release rates for the tablet without lignin, and the tablets 
containing lignin are represented in Figs. 4 and 5, respectively. The graphs of release rate indicate 
that the release rate is very high at the beginning of dissolution test, and more than 60 % of the API 
is released after 5 minutes. After 20 minutes, the drug concentration in the solution reaches the highest 
values, and then decreases, and finally become plateau which is considered as the equilibrium point. 
The reason for reduction in the concentration of API after 20 minutes could be attributed to the 
dissociation of aspirin which undergoes hydrolysis during the dissolution test. Aspirin is partially 
hydrolysed to salicylic acid and acetyl salicylic acid upon exposure to aqueous solutions (Pishnamazi 
et al., 2019).  
It is also observed in Figs. 4 and 5 that the release rate of aspirin is higher in the tablets containing 
lignin such that higher dissolution rate is observed in the dissolution test of tablets containing lignin. 
This could be due to amorphous nature of lignin which enhances the dissolution of aspirin. It is 












































































































































































4.4. Design space for the API release 
The developed model was used to understand the effect of process parameters of roll compaction as 
well as formulation on the release rate of API. In roller compaction process, roll pressure is the most 
important parameter compared to other parameters such as screw speed and roll speed (Pishnamazi 
et al., 2018). The effect of roll pressure and lignin content on the equilibrium concentration of API in 
the buffer solution is shown in Fig. 6. The roll pressure was considered between 30-50 bar, and the 
lignin content between 0-20 wt. %. It is indicated that by increasing the lignin content in the 
formulation, the dissolution of API increases significantly which consequently can enhance the 
bioavailability of API. Also, it is seen that by increasing the pressure, the dissolution decreases, 
however the effect of roll pressure on the dissolution is not significant compared to the effect of lignin 
content because the dissolution of API is highly dependent on the chemistry of formulation and the 
dissolution medium. It is observed that increasing roll pressure decreases the equilibrium 
concentration of API which is attributed to the size of granules. As the roll pressure increases, denser 
ribbons are produced, which results in formation of larger granules in the milling step. Larger granules 
in the prepared tablets results in lower dissolution as the surface area of the granules decreases and 








Figure 6. Prediction profiler; (a) Contours of equilibrium drug release versus roll pressure and lignin 




A new formulation containing lignin was designed in this work to enhance the bioavailability of 
drugs. The tablets were prepared using dry granulation method followed by milling and tableting. In 
order to design and predict the release rate of API, an artificial neural network (ANN) model was 
developed considering two hidden layers and combining various activation functions, i.e. linear, 
hyperbolic tangent, and Gaussian. The ANN model as well as hybrid ANN-Kriging were developed 
to predict the dissolution of the drug. Two formulations, one containing lignin, and the other one 
without lignin were considered to investigate the effect of lignin on the API release rate. The results 
of release rate indicated that the tablets containing lignin have higher release rates of API. The results 
of simulation revealed that the developed model can predict the release rate with high accuracy and 
R2=0.99 was obtained for most cases. The model was used to predict the kinetics and equilibrium of 
the release rate and great agreement was obtained between the predicted and measured data. The 
validated model was then used to understand the effect of process parameters on the release rate, and 
it was revealed that increasing roll pressure decreases the release rate, because larger granules are 
produced which in turn results in lower release rate. 
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MATLAB codes for ANN-Kriging 
syms H1 H2 H3 HH1 HH2 HH3 THETA1 THETA2 THETA3 THETA4 THETA5 THETA6 
THETA7 THETA8 Lignin_content Roll_pressure P_5minP P_10minP P_20minP P_30minP 
P_40minP P_50minP P_60minP P_120minP 
H1 = tanh(.5*(-0.000666184740102217*Lignin_content + -0.262662295436883*Roll_pressure + 
10.7736115523835)); 
H2 = tanh(.5*(-0.136798865827418*Lignin_content + -0.0040891931727841*Roll_pressure + 
3.3928495955642)); 
H3 = -0.00218360187333637*Lignin_content + -0.0534606845680695*Roll_pressure + 
1.59699424536851; 
HH1 = tanh(.5*(0.0573689661011285*H1 + 0.133071274895432*H2 + 4.66486177669116*H3 + 
2.73303458525506)); 
HH2 = tanh(.5*(-0.646613009218206*H1 + 3.53607870921569*H2 + 0.298338609051791*H3 + -
5.69556454905895)); 
HH3 = -3.09553015309569*H1 + -0.223555991654973*H2 + -0.0119944460569438*H3 + 
0.305811189255288; 
THETA1=82.9337628695886*HH1 + -40.4828651722123*HH2 + 26.6942842353261*HH3 + 
28.6416291130038; 




THETA3=70.4357629968306*HH1 + -106.389397832412*HH2 + 23.1996064208961*HH3 + -
19.9013009015741; 
THETA4=84.9814457018386*HH1 + -110.249292252343*HH2 + 27.8655615136839*HH3 + -
24.3081298033377; 
THETA5=86.129712919647*HH1 + -111.103076883315*HH2 + 28.2422914255355*HH3 + -
25.5981943315789; 
THETA6=51.8758851431266*HH1 + -109.255967707215*HH2 + 17.3619957166247*HH3 + -
22.9409067484738; 
THETA7=78.7848318048491*HH1 + -109.616704184623*HH2 + 25.9123561080872*HH3 + -
25.2741546049034; 
THETA8=77.7836793586035*HH1 + -109.89119137311*HH2 + 25.6239094541334*HH3 + -
25.6906303502175; 
P_5minP = THETA1; 
P_10minP = THETA2; 
P_20minP = THETA3; 
P_30minP = THETA4; 
P_40minP = THETA5; 
P_50minP = THETA6; 
P_60minP = THETA7; 
P_120minP = THETA8; 
digetsOld = digits(4); 
P_5minP = vpa(P_5minP); 
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P_10minP = vpa(P_10minP); 
P_20minP = vpa(P_20minP); 
P_30minP = vpa(P_30minP); 
P_40minP = vpa(P_40minP); 
P_50minP = vpa(P_50minP); 
P_60minP = vpa(P_60minP); 
















In the previous three chapters, we studied the lignin characterization, in terms of powder and granules. 
Then we used lignin as excipient to study the effect of that on drug release behaviour. Moreover, we 
modelled the drug release rate using ANN software. All the results were satisfactory. Then, for the 
next step, we decided to modify lignin, as it is a good candidate for chemical modification due to 
different fictional groups on the lignin structure, which is very useful to enhance drug release rate. 
We decided to study the effect of modified lignin on drug release rate and we used another type of 
API, to make sure lignin can be used as excipient in the tablet formulation with different types of 
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Abstract 
The influence of lignin modification on drug release and pH-dependent releasing behaviour of oral 
solid dosage form was investigated using three different formulations. The first formulation contains 
microcrystalline cellulose (MCC101) as excipient and paracetamol as active pharmaceutical 
ingredient (API). The second formulation includes Alcell lignin and MCC 101 as excipient and 
paracetamol, and the third formulation consists of carboxylated Alcell lignin, MCC 101 and 
paracetamol. Direct compaction was carried out in order to prepare the tablets. Lignin can be readily 
chemically modified due to the existence of different functional groups in its structure. The focus of 
this investigation is on lignin carboxylation and its influence on paracetamol control release behaviour 
at varying pH. Results suggest that carboxylated lignin tablets had the highest drug release, which is 
linked to their faster disintegration and lower tablet hardness.  




































Excipients play a significant role in the final product of pharmaceutical solid dosage forms. Variations 
in excipient properties influence tablet processability, hardness, disintegration and bioavailability [1-
3]. Nowadays, many researchers have focused their investigations on using natural biopolymers [4] in 
tablet manufacturing due to their biocompatibility [5,6], also, they are cheap and widely available [7-
9]. Lignin is a natural biopolymer with a number of beneficial properties including biodegradability 
and biocompatibility [10-14]. Recently, the use of lignin is increasing as a sustainable polymer for 
preparing carbon fibers [15], biofuels, bioplastics and controlled release carriers [16-21]. Due to the 
existence of different functional groups in the lignin structure such as; phenolic, hydroxyl and 
carboxyl groups, lignin can be chemically modified to enhance drug delivery and to control drug 
release [22-24]. Figueiredo et al. functionalized Kraft lignin nanoparticles by carboxylation in order to 
improve drug delivery of poorly water-soluble anti-cancer drugs which were pH-sensitive [18]. 
Lievonen et al. modified softwood Kraft lignin using a dialysis technique to improve its drug delivery 
performance [25]. Furthermore, it has been recognized that pH-responsive drug carriers provide 
superior drug delivery characteristics due to their ability to increase stability of API (active 
pharmaceutical ingredient) molecules in the stomach and release API in the intestine [26]. Li et al. 
investigated the release behavior of ibuprofen, using lignin-based complex micelles. The results of 
release tests illustrated a pH-dependent and controlled release properties due to ionization of the 
carboxyl groups in the lignin structure, with repulsive forces between the negatively-charged carboxyl 
groups of lignin and API molecules, with higher solubility of API at pH=7.4 [27]. Chen et al. 
synthesized lignin-based pH-responsive nano-capsules to improve controlled release of poorly water-
soluble drugs by varying pH [28]. Duval et al. studied pH and light responsive behavior of controlled-
release systems containing diazobenzen and modified softwood Kraft lignin [29]. Various 
investigation have been carried out on the effect of lignin-based polymeric nanoparticles (NPs) on 
the controlled release of pesticides [30,31].  
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Bulut et al. studied the controlled-release behavior of paracetamol using chitosan-graft-
polyacrylamide microspheres via an emulsion crosslinking technique [32]. They utilized 
glutaraldehyde (GA) as crosslinker to investigate the effect of that on the drug release rate. They 
mentioned the drug release rate was affected by some parameters such as the amount of GA, 
copolymer concentration and drug and polymer’s composition. Their results illustrated more 
controlled release of drug by increasing the GA amount and copolymer, and decreasing in 
composition (paracetamol/polymer) ratio. Treenate et al. investigated the controlled release properties 
of paracetamol using a novel system composed of hydroxyethylacryl chitosan and sodium alginate in 
order to improve drug delivery for oral dosage forms [33]. Through improving drug water solubility, 
drug efficiency will be improved [34]. The current authors have evaluated the effect of lignin on the 
release rate of aspirin in oral dosage form, and indicated the higher release rate of drug using lignin 
as excipient in the tablet formulation [9].  
In this study, the effect of carboxylated lignin as excipient on paracetamol release behavior was 
investigated. Lignin carboxylation was performed to enhance the carboxyl group content on the lignin 
surface in order to increase the interactions between lignin and paracetamol functional groups and 
allow pH triggered release. To the best of our knowledge, no studies have reported the use of 
carboxylated lignin in paracetamol tablet manufacturing and its effect on the release. Three different 
formulations have been considered, first one without lignin, second one using pure lignin and the 
third one contains carboxylated lignin. Paracetamol is utilized as a model drug in this research, it is a 
nonsteroidal anti-inflammatory [35]. Paracetamol is widely used as a pain relief drug with a fast 
absorption within the small intestine of the human body [36,37]. Tablets were prepared by direct 
compaction and characterized using disintegration and dissolution tests. Modified lignin was verified 
using Fourier-Transform Infrared spectroscopy (FTIR). Drug release rates were measured using 
dissolution tests at pH 5.8 according to United States pharmacopeia (USP) [38]. In order to investigate 
the controlled release behaviour of paracetamol, dissolution tests were carried out at acidic condition 




2.1. Materials and methods 
Paracetamol (4-acetamidophenol, Phion) was used as a model API to prepare three different 
formulations. Microcrystalline cellulose (MCC SANAQ® 101 L USP/NF/EP) and Alcell lignin 
(Tecnaro (Ilsfeld, Germany)) were used as excipients. More details on the lignin used in this study 
can be found elsewhere [2,15]. Table 1 shows the composition of the three formulations considered. 
Table 1. Various formulations used in this study. 
 
2.2 Lignin modification  
In order to allow conjugation reactions between lignin and paracetamol, lignin is functionalized with 
carboxylic acid groups. Synthesis of COOH-lignin involves ring-opening reaction of succinic 
anhydride with 4-dimethylaminopyridine (DMAP). 2 g of lignin, 2 g of succinic anhydride and 400 
mg of DMAP were added to 250 ml of tetrahydrofuran (THF) in a 500 ml round-bottom flask, 
followed by stirring for 48 hr at room temperature [18]. The obtained carboxyl functionalized 
precipitate was filtered, and then, washed for 24 h using deionized water via soxhlet extraction system 
in order to remove the unreacted reagents. Finally, the modified lignin was placed in a freeze-dryer 
overnight. The proposed mechanism pathway [18] is presented in Fig. 1. 
 
 
  Formulations   
Material A B  C 
Paracetamol (% wt.) 20 20  20 
Alcell lignin (% wt.) 0 10  0 
Modified Alcell lignin (% wt.) 0 0  10 




Figure 1. Mechanism of lignin carboxylation. 
 
2.3. Tablets preparation 
In order to prepare tablets, a single-punch tablet press (Gamlen Tableting GTD-1 D series, UK) was 
utilized. 100 mg of each formulation were compacted to make each tablet in a 6 mm die. The tablet 
load was set at 400 kg, with compaction rate of 180 mm/min. 
2.4. Characterisation 
Fourier transform infrared spectroscopy (FTIR, ThermoFisher, Ireland) measurements was carried 
out utilizing a Nicolet Nexus FTIR spectrometer between 450–4000 cm−1 equipped with an 
attenuated total reflectance accessory (ATR), a total of 60 scans with a spectral resolution of 2 cm−1. 
Tablet hardness was measured using a tablet hardness tester, Pharma Test (PTB 311E 3 in 1 hardness, 
diameter and thickness tester, Hainburg, Germany). Pharma Test PTZ-DIST- Disintegration Test 
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Instrument (Hainburg, Germany) was used to measure the tablet disintegration time. 900 mL of 
deionized water was filled out the apparatus vessel and the peddle speed was kept constant at 100 
rpm. The temperature of vessel was adjusted at 37 ̊ C. The tests were performed for those two 
formulations containing pure lignin and carboxylated lignin until the tablets completely disintegrate. 
A Pharma Test PTWS 120D 6-Station Tablet Dissolution Testing Instrument (Hainburg, Germany) 
was utilized to analyse the tablets dissolution rate. For drug concentration measuring, Cary 60 UV 
Spectrophotometer (Agilent Technologies, Waldbronn, Germany) was used in 249 nm wavelength. 
All the tests were carried out in triplicate. The calibration graph can be found in Supplementary 
Information. 
2.5. Dissolution test procedure 
Phosphate buffer with pH=5.8 (according to USP 23) was used as dissolution medium [38,39]. 900 
mL of medium was prepared to fill each dissolution vessel. The temperature of medium chamber and 
the stirrer speed were considered to keep constant at 37 ± 0.5 ̊ C and 50 rpm respectively. For running 
the dissolution test, first, the temperature should reach to 37 ̊ C. For each run, three vessels were 
utilized and one tablet was considered for each vessel. Five mL of sample were withdrawn at 5, 10, 
20, 30, 40, 50, 60 and 120 minutes from each vessel and the same amount of medium was supplant, 
instantly. Afterwards, the samples were filtered applying Captiva Econofilters (PTFE membrane, 13 
mm diameter, 0.2-µm pore size. Eventually, all samples were analysed to measure the drug 
concentration using Cary 60 UV Spectrophotometer at 249 nm wavelength, which was calibrated to 
find the wavelength. The cuvette type was 1/Q/10, quartz with pathway of 1cm. In order to minimize 
the statistical error, all the experiments were done in triplicates. For the dissolution tests of pH-
responsive analysis, due to the evaluation of the controlled release behaviour of paracetamol in 
carboxylated lignin formulation, two different pHs were considered, phosphate buffer solution, 




3. Results and discussion 
3.1. FTIR characterization of pure lignin and modified lignin 
The FTIR spectra analysis was carried out to monitor the pure lignin structure and to characterize the 
chemical changes in the functional groups of lignin structure during the carboxylation reactions. Fig. 
2 shows the spectra of pure lignin and functionalized lignin, which have similar peaks such as; C=O 
(carbonyl groups) at 1600 cm-1, –OH (hydroxyl groups) which are attributed to the phenol and 
alcohol in the region of 3600–3100 cm-1 and aromatic ring region at 1425-1514 cm-1. Nevertheless, 
hydrogen‐bonded hydroxyl stretching band of carboxylic acid (2250–3600 cm−1) and the stretching 
vibrations of C=O of the unconjugated –COOH groups at 1720 cm-1 exhibit a stronger absorption  
bond than the pure lignin (unmodified), proving that grafting lignin with carboxylic acid groups has 
been successfully done. 
 
Figure 2. FTIR spectra of lignin (red) and carboxylated lignin (blue). 
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3.2. Effect of lignin carboxylation on the tablet disintegration time 
Tablet disintegration time effect the tablet dissolution and can be used as a valuable test for solid oral 
dosage forms. Tablet hardness can influence tablet disintegration time, which higher hardness leading 
to longer disintegration times [42,43]. In order to study the effect of lignin carboxylation on the tablet 
disintegration time, disintegration test was performed for three different tablets, non-lignin, pure 
lignin and modified lignin. Fig. 4 presents the disintegration time results; in which faster 
disintegration time for tablets containing modified lignin is obtained. Moreover, tablet hardness is 
measured using a hardness tester (pharma test, PTB) for three formulations, and the results show 
higher hardness with the formulation without lignin (Fig. 3). Tablet hardness is affected by physical 
properties of materials, and interaction of drug with excipient. The tableting method is the same for 
each formulation, in order to mitigate its influence on tablet hardness. Generally, lower hardness 
equals to higher porosity, therefore, the lower hardness or higher porosity of carboxylated lignin tablet 









































Figure 4. Disintegration time of tablets prepared contain pure lignin, modified lignin and non-lignin 
tablet. 
3.3. Effect of lignin carboxylation on drug release rate  
Dissolution tests were performed to evaluate the effect of lignin and carboxylated lignin on the 
paracetamol tablet release rate. The three different formulations in table 1, were considered to study 
paracetamol release rate in phosphate buffer solution at pH 5.8, according to USP [38]. The release 
graphs of three different batches of paracetamol are displayed in Fig. 5. Interestingly, the graphs 
illustrate that the tablets containing functionalized lignin has the highest drug release rate and this 
correlates with the faster disintegration time of these formulations and lower tablet hardness. In 
































Figure 5. Drug release rate of paracetamol for the formulations at pH=5.8. 
Moreover, the prepared tablets containing pure lignin have the higher drug release rate compared to 
formulation without lignin due to faster disintegration and lower tablet hardness [9]. Thus, Lignin 
functionalization improved the release properties of directly compacted paracetamol tablets. 
3.4. Controlled release and pH-responsive behaviour of carboxylated lignin 
The pH-responsive behaviour of carboxylated lignin was investigated using dissolution tests in 
different media at various pH values, 0.1 M HCL solution (pH of 1.2, gastric environment) and 
phosphate buffer (pH 7.2, intestine environment) at 37 ̊ C. The dissolution graphs in Fig. 6 presents 
the greater release rate of drug in buffer with pH=7.2 [40]. Increasing the carboxyl groups results to 
increase drug release at pH=7.2 compared to pH=1.2. In pH=1.2, the electrostatic repulsion between 
lignin carboxyl groups decrease due to protonation of carboxyl groups at lower pH values. However, 
in pH=7.2, due to ionization of carboxyl groups (Pka =4.8) of modified lignin the negatively-charged 
ions repel each other and presumably this leads to an swelling effect similar to how hydrogels swell 































our previous work by adding lignin in the formulation [9]. The results showed higher drug release rate 
for formulation containing lignin. The results of this work reveal that lignin as natural biopolymer is 
a promising compound for using in controlled release system and also for enhancing the solubility of 
active pharmaceutical ingredients. 
 
Figure 6. Drug release rate of carboxylated lignin in pH=1.2 and 7.2. 
4. Conclusions 
The aim of the present study was to evaluate the pH-dependent releasing behaviours of modified 
lignin and the effect of lignin modification on the drug release rate. Lignin modification was 
conducted via carboxylation of lignin functional groups. In order to analyse the carboxyl groups in 
lignin and carboxylated lignin structure, FTIR test was carried out and the results displayed a 
successful carboxylation. The dissolution results illustrate that there is a higher release rate of 
paracetamol from carboxylated lignin tablets, and this is attributed to the lower degree of interaction 
between lignin and the API due to the deprotonation of -COOH groups from modified lignin. 




























Carboxylated lignin tablet at pH 1.2
Carboxylated lignin tablet at pH 7.2
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and intestine pH of 7.2 and the release results presented successful properties of controlled release. 
Additionally, the tablet disintegration tests showed the faster disintegration time with the 
carboxylated lignin tablets compared to pure lignin tablets due to lower hardness of tablets with 
modified lignin. Thus, these investigations presented a successful use of carboxylated lignin natural 
biopolymer as excipient in oral dosage forms for desired drug controlled release.  
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An experimental investigation has been performed that focused on the effect of using Alcell lignin in 
formulations and its influence on granules properties and drug release behavior.   
Chapter 1 introduced a fundamental study on the powder and granule behaviour during dry 
granulation by roll compaction process. Different formulations are considered using various excipient 
in order to characterize excipients properties and their effect on the formulation behaviors. The 
relation between critical process parameters (CPPs), including roll pressure, screw speed and critical 
quality attributes (CQAs) including ribbon density and granule size (D50) are mapped using JMP 
software to develop a process map. The results illustrated the statistically effect of roll pressure on 
the ribbon density and D50 of granules. On the other hand, the effect of screw speed was negligible.  
The results show that a variation in roll pressure has a considerable effect on ribbon density and 
granule size (D50) in the roller compaction process. At higher roll pressure and constant screw speed, 
the amount of powder between rolls are constant and more pressure leads to more densification of 
powder, especially for smaller particle sizes, cohesive and compressible powders, which results in a 
higher density and larger D50 of granule size. On the other hand, it was found that screw speed does 
not have any significant effect on critical quality attributes of products; however, it affects other 
process variables such as the amount of powders, roll gap, and residence time of powders between 
rolls. 
Another important objective of this study was to investigate the capability of Alcell lignin as a natural 
polymer to use as an excipient to improve powder properties, costs and delivery of tablets as final 
products. Alcell lignin, as a natural polymer can improve granulation process because of good 
flowability, low cost and ease of availability. Interestingly, it was revealed that less operational 
limitations were observed when lignin was introduced as an excipient in the formulations. 
Specifically, the work shows: 
• The relation between critical process parameters (CPPs) and critical quality attributes (CQAs) 
by process map 
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• The significant effect of roll pressure as a key process parameter on the ribbon density and 
granule size (D50) 
• The influence of Alcell lignin as an excipient to improve powder and granule properties in 
different formulations 
• The applicability of NIR spectroscopy as a PAT tool for on-line measurement of ribbon 
density in roll compaction process  
Chapter 2 focused on the effect of lignin-based excipients on the release rate of oral dosage aspirin 
tablets. In this study, Alcell lignin is used as an excipient to show the effect of natural polymer on the 
drug release rate. Dry granulation by roll compaction was used to prepare tablets. Lignin was selected 
as an excipient to evaluate its influence on release rate and tablet properties at varying processing 
conditions due to its chemical structure. Different formulations are considered to compare the effect 
of lignin on the API release rate.  Results illustrated that lignin tablets compared to non-lignin tablets 
have higher hardness, faster disintegration time, and higher release rate. Indeed, the critical quality 
attributes of the tablets were improved by introducing the lignin. Higher release rate of tablets with 
lignin formulation are due to the amorphous structure of lignin and interaction with the API, which 
improves drug solubility and therefore bioavailability, the key factor in oral dosage development. On 
the other hand, higher roll pressure leads to more densified ribbons associated with lignin blends and 
consequently, larger granules are produced. These larger granules result in porous tablets, which leads 
to faster disintegration times as solvent diffuses faster into the tablets. Also, greater hardness for the 
tablets containing lignin is attributed to better affinity between lignin and MCC which leads to lignin 
acting as a tablet binder. 
The work shows: 
• Higher drug release rate by adding lignin as an excipient in the formulation 
• The effect of roll pressure as key process parameters on the tablet disintegration time 
• The use of lignin as an excipient in oral dosage form  
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In chapter 3, the work focused on the design and prediction of drug release rate using artificial neural 
network (ANN) model considering two hidden layers and combining various activation functions, 
i.e.  linear, hyperbolic tangent, and Gaussian. Two formulations, one containing lignin, and the other 
one without lignin were considered to investigate the effect of lignin on the API release rate. The 
tablets were prepared using dry granulation method followed by milling and tableting. A new 
formulation containing lignin was designed in this work to enhance the bioavailability of poorly 
soluble water drugs. The results of release rate indicated that the tablets containing lignin have higher 
release rates of API. The results of ANN modelling revealed that the developed model can predict 
the release rate with high accuracy and R2=0.99 was obtained for most cases. The model was used to 
predict the kinetics and equilibrium of the release rate and consensus was obtained between the 
predicted and measured data. The validated model was then used to understand the effect of process 
parameters on the release rate, and it was revealed that increasing roll pressure decreases the release 
rate, because larger granules are produced which in turn results in lower release rate. 
The works show: 
• The effect of lignin on the API release rate using ANN model 
• The effect of roll pressure as a process parameter on the drug release rate  
• Higher roll pressure resulted in larger granules and decreased the drug release rate 
The work in chapter 4 introduces the lignin functionalization to use as an excipient in oral dosage 
formulation in order to investigate the effect of that on pH-sensitive behavior and release rate of drug. 
Lignin modification was conducted via carboxylation of lignin functional groups. Interestingly, the 
dissolution results illustrated higher release rate of paracetamol with the carboxylated lignin tablets, 
which is attributed to the enhancement of electrostatic repulsions between -COOH groups of modified 
lignin and functional groups of paracetamol. Furthermore, controlled release behaviour of 
carboxylated lignin was performed in gastric pH of 1.2 and intestine pH of 7.2 and the release results 
presented successful properties of controlled release. Additionally, the tablet disintegration tests 
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showed faster disintegration with the carboxylated lignin tablets compared to pure lignin tablets. 
Thus, these investigations presented a successful use of lignin as an excipient in oral dosage forms 
for desired drug controlled release. 
The work shows: 
• Lignin cab be functionalized by increasing the carboxyl groups in lignin structure 
• pH- responsive behaviour of drug release through the addition of modified lignin in the oral 
dosage formulation 
• Drug release enhancement is attributed to:  
 The faster disintegration time of these formulations and lower tablet hardness. 
 The increase in the ionization degree of carboxyl functional groups in carboxylated lignin 
tablet compared to lignin and non-lignin containing tablets and the electrostatic repulsions of 
functional groups in drug molecules (hydroxyl and amides) and –COOH of modified lignin 
lead to a burst-release of drug. 
Future work     
The main issue in the pharmaceutical industry is to improve drug delivery and drug release rate. PH-
responsive behavior of drugs is a big challenge to improve, especially in cancer disease. Recently, 
many researchers are focused on these challenges using natural biopolymers due to their 
biocompatibility and biodegradability properties [1, 2, 3, 4, 5 and 6]. 
Upgrades are: 
• To look into whole process chain of RC, milling and tableting 
• use of X-ray CT to characterise porosity of tablets 
• The use of biopolymers to prepare nanocarriers for drug delivery 
• Development of continuous manufacturing based on lignin formulation and integrated 
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Available online 3 July 2018In this study, a process map was developed in an effort to improve the understanding of dry granulation of phar-
maceutical excipients by roll compaction process, and to implement the quality-by-design (QbD) approach.
Through development of the process map, a correlation was made between the critical process parameters
(roll pressure, screw speed), and critical quality attributes (density of ribbons and granule size). This method
reduces development time, quantity of materials required and cost. A new excipient formulation based on natu-
ral polymers (lignin and cellulose)was utilised to improve theproperties and reduce costs associatedwith tablets
production. A variety of lignin, microcrystalline cellulose (MCC) and lactose monohydrate formulations were
compacted followed by milling to obtain granules. Formulations were also characterised in terms of compress-
ibility and flowability. Density of ribbons as well as granule size distribution weremapped versus critical process
parameters. Based on this work as initial study, roll pressure was found to be a critical process parameter, higher
ribbon density and larger granule size obtained with higher roll pressure. It was also revealed that the process
map is a powerful tool in understanding the dry granulation, and canbe used to construct a design space for phar-
maceutical manufacturing.









The current practice in pharmaceutical manufacture is batch wise in
which trial and error approach, which is time-consuming and wasteful
is used for new formulations and equipment. Recently, continuous pro-
cessing has receivedmore attention in the pharmaceutical industry as it
offers superior characteristics compared to batch processing [1]. Upon
developing continuous processing, we can avoid scale-up issues, reduce
cycle times, variability and production costs, ensure faster product
release, increase flexibility and efficiency, and improve product quality
[2, 3]. Underpinning research is required to transform batchmode oper-
ation to the continuous mode. One of the key processing steps in the
pharmaceutical manufacturing is granulation, as the properties of final
products are dependent on the granule properties. In themanufacturing
process, active pharmaceutical ingredients (API) and excipients mix-
tures are granulated to improve flowability and content uniformity of
the particles. There are two main methods for granulation of pharma-
ceutical formulations, namely dry and wet granulation [4, 5]. In wet
granulation, liquid binders are used to form granules from fine powder,mazi).whereas in dry mode no binder is required. Indeed, dry granulation is
useful for compounds that are sensitive to heat and moisture [6–8].
Roll compaction (RC) is widely used for dry granulation as a continuous
process, and has shown more advantages, for example, a reduction in
powder segregation and increasing bulk density [7, 9–11].
During roll compaction, fine powder is compacted between two
counter-rotating rolls to produce ribbons (briquette) by applying
hydraulic force on powder. The ribbons are milled to produce granules,
and then compacted to form tablets [11, 12]. As such, controlling ribbon
density and granule size are critical in RC process. Therefore, application
of RC would promote the paradigm of continuous pharmaceutical
manufacturing. In order to develop a continuous line for manufacturing
of solid-dosage forms, the process understanding is of great importance
so that the critical quality attributes of products are correlated with the
process parameters and material properties [13–16].
Themechanismof the dry granulation process is still notwell under-
stood in the continuous pharmaceutical manufacturing context. Several
models have been deployed such as Johansonmodel, slabmethod,finite
elementmethod, discrete elementmethod and artificial neural network
to correlate the process parameters with ribbon density. These models
are of mathematical basis and are used to predict process variations
[8, 11–13, 16, 17]. In addition, several researchers have studied different
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density [18–23].
McAuliffe et al. [24] studied the effect of roll pressure on density of
ribbons prepared with a formulation containing MCC 102, anhydrous
lactose, and they highlighted the impact of roll pressure on ribbon and
granule properties at constant screw and roll speed with variable roll
gap. They mentioned increasing the roll pressure causes decrease in
the roll gap. In addition, it was shown that increasing the roll pressure,
have a significant effect on ribbon and granule properties. Souihi et al.
[25] investigated the influence of process parameters on ribbon density
using the Johanson model for the formulation containing paracetamol,
mannitol, andMCC 102. Theymentioned that Johansonmodel describes
the effect of roll pressure and screw speed on ribbon density and
emphasised the minor effect of roll gap on ribbon density compared to
roll pressure. Khorasani et al. [21] also studied the effect of roll pressure
and roll speed on ribbon density utilising a formulation containingMCC
101 and acetylsalicylic acid with the constant roll gap. Moreover, the
screw speed was adjusted automatically to keep the roll gap constant.
It was also shown that increasing the roll pressure leads to increase
the ribbon density and granule size. On the other hand decreasing the
roll speed results in increasing ribbon density and granule size due to in-
creased residence time of powder between rolls. Kumar et al. [26] stud-
ied the influence of process parameters on quality attributes of the wet
granulation process by developing a regime map for a formulation
consisting ofα-Lactosemonohydrate and PVP. Itwas shown that the re-
gimemap provides a design space for optimisation of granulation. Sajjia
et al. [2] analysed the effect of process parameters on ribbon density
using of MCC 102, and further explained the effect of roll pressure and
screw speed on ribbon density. They believed that increasing the roll
pressure leads to ribbons with higher density. They further highlighted
the unstable and minor effect of screw speed on ribbon density.
As mentioned, different researchers have studied the effect of pro-
cess parameters on ribbon density and particle size of granules, but
development of a comprehensive process map, which is capable of pro-
viding a design space for roll compaction process, is of great importance.
Furthermore, the effect of formulation on the ribbon and granule prop-
erties has not been studied. None of these investigations have shown
the correlation between process parameters and quality attributes by
mapping the process, and understanding the influence of material
formulation.
Indeed, a comprehensive understanding the process for various for-
mulations is of great importance. In order to determine the best design
space in dry granulation processing, one may need to use a wide range
of DoE (design of experiments) to fully understand the effect of under-
lying parameters on ribbon properties as well as granule size. Develop-
ment of a design space for dry granulation can be achieved with a
process mapping, which correlates the process input to the outputs for
a wide range of formulations. Recently, several researchers have
attempted to show the importance of identifying the interaction
between process parameters ofmaterials and quality attributes of prod-
ucts for roll compaction process. They have utilised dimensionless vari-
ables for roll compaction, and regime maps for wet granulation
processing have been investigated [15, 23, 26–28]. The process map
has been successfully developed for wet granulation via twin-screw
extruder [26], and it was shown that the process map concept is
of great importance for the development of continuous manufacturing.
Therefore, it would be of great importance to develop a process
map for dry granulation by roller compactor considering new
formulations.
Lately, due to different issues in terms of side effects and drug
release, use of natural polymers has attracted much attention on the
development of tablet formulations through usage of new excipients.
Natural polymers offer a number of advantages as excipients in tablet
manufacture including; low or no toxicity, regulatory compliance and
stability, while enhancing the physicochemical properties of powders
and increasing drug release rates. Due to the high chemical functionalityof lignin, it can be introduced as a novel excipient for development of
new materials [29–37].
In the present study, a process map has been developed for RC pro-
cessing with various formulations including the novel lignin excipient.
Different formulations with differing percentages of microcrystalline
cellulose (MCC), lactose and Alcell lignin were designed and used
throughout the experiments. For designing the process map, a correla-
tion between input variables including roll pressure, screw speed, and
ribbon properties such as density as well as D50 of granules was
found. This method reduces development time, quantity of materials
and cost. It should be noted that these process maps are a preliminary
study and are limited to the specific type of formulations and equipment
used in the experimental design. Moreover, in order to assess the appli-
cability of NIR spectroscopy as a PAT tool for on-line monitoring of RC,
the density of ribbons containing bio-based materials were analysed
using the NIR method. However, it was conducted as an off-line exper-
iment and for limited samples.
2. Experimental procedure
2.1. Materials and methods
Microcrystalline cellulose (MCC SANAQ® 102 L USP/NF/EP), lactose
monohydrate (Lennox USP, NF, BP, Ph, pure pharma grade) and Alcell
lignin (Tecnaro, Ilsfeld, Germany) were used as excipients throughout
the experiments. In order to prepare the excipient mixtures, microcrys-
talline cellulose, lactosemonohydrate and Alcell organosolv ligninwere
mixed with 0.5% w/w magnesium stearate (Sigma-Aldrich), which
acted as lubricant. For further details on the lignin used in this study
the authors are referred to [38]. Two different formulations were con-
sidered, first, MCC was mixed with 5, 10 and 20 wt% of lactose, and
then MCC was mixed with 5, 10 and 20 wt% of Alcell lignin. All compo-
nents were blended using a Morphy Richards Stand Mixer with beater
attachment at speed setting 3 (100 RPM approx.) for 15min.
2.2. Equipment and analysis
A top-fed roller compactor “Freund TF-MINI” (see Fig. 1) with a ver-
tical screw feeder was utilised throughout the RC experiments. The
width and diameter of rolls were 25 and 100 mm, respectively. The
roll speed was set at 4 rpm for all experiments. Process parameters,
screw speed (SS) and roll pressure (RP), were changed with variable
screw speed (8–18 rpm) by 2 rpm step and roll pressure (10–50 bar)
by 5 bar step. An envelope density analyser, (GeoPyc 1360,
Micromeritics Instrument Corp., Norcross – USA) was used to measure
the ribbon density. The roll gap was uncontrolled and variable during
the experiments. The thickness of produced ribbons was measured to
be between 1 and 3 mm for all samples.
In addition, amultipointNear-Infrared (NIR) spectrometer,Multieye
NIR, was utilised to characterise the ribbon density. The NIR spectra
were calibrated using the density obtained via the GeoPyc instrument
and developing a calibration model. Partial Least Square (PLS)
technique was used for calibration of NIR results. The produced ribbons
weremilled with a conical mill (Laboratory Comil 193 AS)with 813-μm
mesh size at 3000 rpm mill speed to produce granules.
The particle size distribution (PSD) of powders and post-milling
granules were measured using Microtrac S3500 particle size analyser
(Malvern). Powder flow and compressive behaviour of materials were
evaluated using powder flow rheometer (Freeman Technologies FT4).
For characterising the morphology of powders, scanning electron mi-
croscopy (SEM) was performed under vacuum. Particle shape and sur-
face morphology of the powders were examined using a scanning
electronmicroscope, (Hitachi TM-1000 desktop SEM). Schematic repre-
sentation of the roller compactor and the photo of sieve mill and RC are
shown in Fig. 1.
Fig. 1. Freund roller compactor and mill used in experiments.
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3.1. Effect of process parameters on ribbon density
In order to implement the quality by design (QbD) approach for roll
compaction process, first, a relationship between process parameters
and quality attributes of products should be defined. For developing a
basic understanding of dry granulation process by roller compactor,
the effect roll pressure and screw speed on ribbon envelope density
are plotted by using JMP 12 pro software and shown in Fig. 2. Asexpected, the ribbon envelope density is greatly influenced by roll pres-
sure, while screw speed has minor effect on the density.
It should be pointed out that in some cases, insufficient data were
collected due to process limitations at these operating conditions. It is
observed that applying more roll pressure, at constant screw speed,
leads to denser powders, and consequently produced ribbons with
higher density for all samples. Higher roll pressure under constant
screw speed leads to more compaction between two rotating rolls and
thereby higher density of ribbons. In other words, in constant screw
speed, the amount of powders and powder residence time between
Fig. 2. Effect of process parameters on ribbon density for various formulations.
41M. Pishnamazi et al. / Powder Technology 341 (2019) 38–50the rolls are constant as well, and more pressure results in more roll
force andmore densification of ribbons. The graphs of different percent-
ages of lactose illustrate wide range of process parameters, while the
graphs with lignin show more limitations in terms of screw speed.
Furthermore, it is observed that at the same content of lactose and
lignin in the formulation, higher ribbon density is obtained for theformulation containing lignin, which could be attributed to the intrinsic
physical and chemical properties of lignin and interaction with MCC,
which will be further investigated in the next section. On the other
hand, as it can be seen in Fig. 2, screw speed has a minor influence on
the ribbon density for all formulations. For each formulation with the
same roll pressure, increasing the screw speed results in increased
Fig. 3. Contours Plot for Density (g/cc), Formulation= 5, 10 and 20% Lactose.
Fig. 4. Contours Plot for Density (g/cc), Formulation= 5, 10 and 20% Alcell lignin.
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process parameters are observed for higher percentages of lactose for-
mulation. The results confirm that lignin is a promising bio-based excip-
ient for tablet manufacturing and almost similar behaviour with
common excipients (e.g. lactose) was observed for the formulations
containing lignin.3.2. Effect of formulation on density of ribbons
To investigate the effect of the formulations used on the density of
the produced ribbons, contours of density versus roll pressure and
screw speed for different formulations are plotted as shown in Figs. 3
and 4. These contours show the two-dimensional colour representation
Fig. 5. Cohesion and flow function graphs for Lactose, Alcell lignin and MCC 102 measured by FT4 powder rheometer.
Fig. 6. SEM of Lactose (A), MCC 102 (B) and Alcell lignin (C), and particle size distributions (D).
43M. Pishnamazi et al. / Powder Technology 341 (2019) 38–50for the relationship between process parameters specified and the rib-
bon density.
Fig. 3 shows the contours of formulation with lactose at different
percentages in which the white area, at the background of the map,
indicates the process limitations. The latter means that the experiments
cannot be conducted due to operational problems such as roller block-
age, over compaction, etc. In terms of blockage ofmaterials, it happened
at the end of screw feeder, the neck of hopper, in the slip region (seeFig. 1). As such, these contours also indicate the workability of RC in
which the colour areas correspond to the working conditions of
equipment.
It is observed that increasing the percentage of lactose results in
higher density and less limitation in the process parameters. Further-
more, by increasing the percentage of lactose, the effects of screw
speed on ribbon density decay. At 5% of lactose, increasing the screw
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Fig. 7. Compressibility of Lactose, MCC 102 and Alcell lignin measured by FT4 powder rheometer.
44 M. Pishnamazi et al. / Powder Technology 341 (2019) 38–5010% of lactose, the screw speed influence is slight, and for 20% of lactose
it does not have any appreciable effect (see Fig. 3)which is in agreement
with literature [8, 24].
Fig. 4 illustrates the contours of formulationswith different percent-
ages of Alcell lignin including 5, 10 and 20 wt. percentage. The plots
show less limitation in terms of roll pressure specifically with higher
percentage of Alcell lignin. Therefore, addition of lignin would improve
the process in terms of limitation and a vast range of process parameters
can be used for the formulations containing lignin. In terms of the effect
of process parameters on ribbon density, higher roll pressure results in
higher ribbon density for all percentages of Alcell lignin. Nevertheless,
the effect of screw speed on ribbon density is almost negligible. Increas-
ing the screw speed while keeping the roll pressure constant, does not
have considerable effect on ribbon density for formulations containing
lignin. Given that the roll gap was variable in the experiments, increas-
ing the screw speed increases the amount of powder pushed between
the rolls, therefore, the gap between the rollers increases which corre-
sponds to the increase of the ribbon thickness. Now, increasing the rib-
bon thickness decreases the stress applied on the powder as the force
will be distributed over wider thickness of powder. However, this phe-
nomenon is not envisaged to be significant compared to the effect of roll
force.
In order to understand the behaviour of various formulations during
the roller compaction process, the Stability Index (SI) of different blends
were measured by FT4 powder rheometer. The stability index of 1 is
ideal and implying that thematerial does not change during the charac-
terisation. An appropriate explanation is provided in the Appendix
about the stability index. The SI of the blends, containing 5%, 10% and
20% lignin were 0.729, 0.752, and 0.840 respectively. It implies that by
increasing the lignin content in the blends, the stability of the powder
blends increases. Moreover, the contours graphs show the higher stabil-
ity for the blendswith higher lignin percentage. On the other hands, the
stability indexwasmeasured for the lactose blends aswell. The SI of 5%,
10% and 20% lactose were 0.891, 0.714 and 0.587 respectively. These
results illustrate that increasing the lactose percentage, leads to
decrease in the blend stability.
For better understanding, the effect of formulations andmaterials on
quality attributes of roll compaction process, flowability and cohesionfor different materials used in this work weremeasured by FT4 powder
rheometer and represented in Fig. 5.
It is observed that Alcell lignin has a better flowability (Flow Func-
tion = 6.38, easy flow) than lactose (FF = 3.54, poor flow). The
methods and equations used for measuring powder flowability are de-
scribed in Appendix A. On the other hand, lactose has greater cohesion
(1.27 kPa) than Alcell lignin (0.611 kPa) and MCC (0.384). To analyse
the effect of particle size and shape on the properties of materials, PSD
and SEM characterisations were carried out. Fig. 6 presents the parti-
cle size distribution and SEM of the three used excipients. Image A
and PSD of lactose show a wide range of particle size, which results
in poor flow behaviour. Image C and PSD of Alcell lignin illustrates a
wide range of particle size, similar to lactose, but with lower cohesion
which causes easy flow. On the other side, image B and PSD of MCC
102 demonstrates a narrow particle size distribution, which leads to
free flow behaviour. As it is demonstrated in the particle size graph,
lactose and lignin have almost similar particle size (D50 = 37 μm),
but MCC 102 has larger particles with a narrower range of particle
sizes with more uniformity and higher flowability. In addition, Fig. 7
indicates the results of compressibility of the excipients measured by
FT4 powder rheometer via compressibility test. Compressibility is a
useful indicator of powder flowability, if it is cohesive or free flowing
[39, 40].
As seen in Fig. 7, lactose shows the highest compressibility among all
excipients, whileMCC 102 has the lowest compressibility. The reason to
use lactose/lignin as excipient is to improve the compaction behaviour
of MCC 102 in the manufacturing process. Also, it is seen that lignin
can be used to improve the compressibility of MCC 102 during the RC
process.
The process map indicates that higher compressibility leads to a
wide range of process parameters for different formulations containing
lactose. However, lactose is cohesive material and poor flowing, and
introducing lignin can improve the flow behaviour of formulation. A
wide range of screw speeds for the blends with different percentages
of lactose are shown in Fig. 3 [29–31]. For the lignin, low range of
screw speed can be applied during the process (see Fig. 4). It means
that at higher screw speed, more powders are pushed between the
rolls and increasing screw speed would result in blockage due to less
Fig. 8. Graphs of compressibility (CPS) of different blends measured by FT4 powder
rheometer.
Fig. 9. Effect of process parameters on D50 of granules for lactose formulations.
45M. Pishnamazi et al. / Powder Technology 341 (2019) 38–50compressibility of lignin compared to lactose. On the other hand, higher
screw speed works better with more compressible materials like lac-
tose. Comparing the cohesion of lignin andMCC, lignin has higher cohe-
sion, and increasing the percentage of ligninwould result in less process
limitations. The higher ribbon density for formulations containing ligninas observed in Fig. 4, can be attributed to the affinity and interaction
between lignin and MCC 102 as both materials are of cellulosic nature.
Physical properties of powders have an important influence on the
quality attributes of products.We have to investigate the physical prop-
erties of materials and the behaviour of them as a component in the
formulations. There is a relationship between particle size of powders
as an inherent properties and their surface area. Materials with smaller
particles have larger surface area, which cause them to be more com-
pressible than the material with larger size. Therefore, lactose with
Fig. 10. Effect of process parameters on D50 of granules for Alcell lignin formulations.
Fig. 11. Contour plot for d50 of granules (microns), formulation = 5, 10 and 20 wt%
lactose.
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tends to be more compressible compared to MCC 102. For lactose, by
increasing applied stress the compressibility increases due to smaller
size which results in more efficient inter-particle packing.
To further understand the effect of blends properties on quality attri-
butes of products, the results of different blends characterisation by FT4
powder rheometer are demonstrated in Fig. 8. The results confirm that
blends with differing lactose percentages have higher compressibilitythan the blends with differing Alcell lignin percentages. For example,
as shown in the Fig. 8A, due to the highest percentage of cohesion of lac-
tose, the blends with lactose are more compressible.
3.3. Effect of process parameters on D50 of granules
Another critical quality attribute for dry granulation using roll
compaction is granule size, as the tablet properties are dependent on
the granule size. The produced ribbons were then milled to obtain the
desired granules. For this section, D50 of granules was used as
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Fig. 14. Predicted versus measured ribbon density calculated by NIR.
47M. Pishnamazi et al. / Powder Technology 341 (2019) 38–50representative granule size. The effect of process parameters on D50 of
granules for different formulations are illustrated in Figs. 9 and 10.
Thesemaps are plotted by using JMP 12 pro software for D50 of granules
versus roll pressure and screw speed. Fig. 9 illustrates the correlation
between process parameters and D50 of granules for 5, 10 and 20 per-
centages of lactose. For each formulation, higher roll pressure leads to
greater D50 at constant screw speed. As discussed, because of smaller
particle size of lactose compared toMCC 102, the blends containing lac-
tose are more compactible. Increasing the lactose percentage leads to
denser ribbons, and consequently results in larger granules becausemore shear force is needed to break up the ribbons in the mill for gran-
ule formation. In addition, it is seen that the effect of screw speed on
D50 at constant roll pressure is almost negligible. Moreover, in the
highest percentage of lactose (20%), due to inherent properties of lac-
tose such as cohesion, a narrow range of screw speed and a wide
range of roll pressure are observed. Due to higher cohesion of lactose
than MCC 102, in the higher percentage of lactose, there are more limi-
tations. In Fig. 10, the correlation between process parameters and D50
of granules for 5, 10 and 20percentages of Alcell lignin are shown. These
maps present a narrow range of screw speed and a wide range of roll
pressure for these formulations. Because of Alcell lignin properties in-
cluding less compressible and less cohesion, smaller D50 of granules
were observed for formulations containing lignin. On the other hand,
for different formulations of Alcell lignin, increasing the percentage of
lignin leads to larger D50 of granules because of smaller particle size
of lignin than MCC 102, higher compressibility and higher cohesion of
lignin.
3.4. Effect of formulation on D50 of granules
The contours of D50 of granules versus roll pressure and screw speed
are designed for different formulations of lactose and Alcell lignin, as
shown in Figs. 11 and 12. Thesemaps describe the limitations of process
parameters and equipment as discussed before. The generation of
uncontrolled fines is a common problem in dry granulation process.
During milling process to produce granules, the particles, which are
≤125 μm, are known as fines [41]. In addition, the area in the process
mapwith particle size smaller than 125 μm for each formulation reveals
the amount of fines produced which should typically be avoided.
Fig. 12 indicates the correlation between process parameters and
D50 of granules for different percentages of Alcell lignin. The same
trend was observed for formulation with Alcell lignin. Higher percent-
ages of Alcell lignin leads to larger particle size of granules and less
percentage of fines. As discussed before, the compressibility of different
blends with lactose are higher than Alcell lignin. It is concluded that,




48 M. Pishnamazi et al. / Powder Technology 341 (2019) 38–50and stronger ribbons, then, larger granule size. Less percentage of fines
and bigger granule size are observed with 20 wt% of Alcell lignin com-
pared to lower lignin content. Also, as seen, higher roll pressure leads
to greater D50, while as mentioned before, screw speed does not have
any serious effect on D50.
These plots, Figs. 11 and 12, also show that the amount of fines (par-
ticles ≤125 μm) are dependent on the roll pressure, increasing the roll
pressure leads to denser powders, and larger granule size, result in a
reduction in the amount of fines. At a constant roll pressure, increasing
the screw speed results in enhancement of the particle size of granules
for 5 and 10 wt% of lactose formulation. However, for 20% of lactose, the
screw speed does not have any important influence on particle size of
granules, in addition, the map shows more stability. By increasing the
roll pressure, the influence on particle size of granules is more
prominent.
4. NIR spectroscopy
NIR spectroscopywas conducted to correlate the obtained spectra to
the ribbon density obtained by roller compaction. The aim is to evaluate
the applicability of NIR as a process analytical tool (PAT) for develop-
ment of continuous pharmaceutical manufacturing. The NIR spectros-
copy has the ability to be used as on-line measurement tool of critical
quality attributes of granules and ribbons such as density [21, 22, 24].
In order to evaluate the applicability of NIR for characterisation of vari-
ous formulations and formulations containing lignin, the produced rib-
bons were characterised by a NIR probe to measure the envelope
density. Off-line NIR spectroscopywas used byMultieye NIR instrument
with the wavelength range of 1500–2200 nm and one probe to moni-
toring of Critical Quality Attributes. The NIR absorbance was found to
be proportional to the envelope density of the ribbons. Partial Least
Square (PLS) regression analysis was used for the calibration of the
NIR results [22]. Cross validation analysis was conducted to calculate
the numbers of principal components and the optimum number of
components was obtained to be seven as shown in Fig. 13. Utilising
seven PLS components show N98% variance in ribbon density. However,
considering higher PLS components may cause over-prediction, which
is a major problem in estimation of ribbon density. Once the model
has been built and calibrated, it can be used to measure the envelope
density using the NIR spectra as inputs. The PLS regression results are
shown in Fig. 14 where it can be concluded that the built PLS model is
capable of calibrating the NIR spectrum to the density of the ribbons
with an R-squared of 0.98 as shown in Fig. 14.
5. Conclusions
The main objective of this study was to implement the quality-by-
design approach to identify the correlation between critical process
parameters (CPPs) and critical quality attributes (CQAs) of outputs
from a dry granulation by roller compaction process. A variety of excipi-
ents with differing formulations were prepared and used in roll compac-
tion process to produce ribbons and granules. Microcrystalline cellulose
(MCC 102) was used as the base excipient, as it is a common widely
used material in dry granulation process due to its inherent properties
such as good compressibility because of fibrous structure and high
capacity. Other formulations containing lactose and Alcell lignin were
considered to understand the influence of formulation on the CQAs.
The effects of CPPs including roll pressure and screw speed on the
CQA, including ribbon density as well as D50 were investigated. The
results indicated that a variation in roll pressure has a considerable
effect on ribbon density and granules size (D50) in the roller compaction
process. At higher roll pressure and constant screw speed, the amount of
powder between rolls are constant and more pressure leads to more
densification of powder, especially for smaller particle size, cohesive
and compressible powders, and results in a higher density and larger
D50 of granules size. On the other hand, it was found that screw speeddoes not have any significant effect on critical quality attributes of
products, and it affects other process variables such as the amount of
powders, roll gap, and residence time of powders between rolls.
It was revealed that the properties and percentages of different
excipients constrain the operability of the parameters used in roller
compaction. However, as the processmap is dependent on the formula-
tion and equipment, generalisation of these process maps are needed
based on dimensionless variables. The differences in mechanical prop-
erties of excipients leads to some differences in compaction behaviour
during RC. Lactose shows higher compressibility than MCC 102 and
Lignin. Therefore, lactose with smaller particle size, and larger surface
area with increased particle contact tends to be more compressible
thanMCC102, and can beused asmodifier in theRCprocess. Also, lignin
indicated almost similar behaviourwith lactose, and can be a promising
excipient in tablet manufacturing.
Another important objective of this study was to investigate the ca-
pability of Alcell lignin as natural polymer to use as excipient to improve
powder properties, costs and delivery of tablets as final products. Alcell
lignin, as a natural polymer can improve granulation process because of
good flowability, low cost and ease of availability. Interestingly, it was
revealed that less operational limitations was observed when lignin
was introduced as an excipient in the formulations.Moreover, the appli-
cability of NIR spectroscopy as PAT tool for on-line measurement of rib-
bon density in roller compaction process was investigated and NIR has
been shown to be robust and reliable enough to be used as an on-line
measurement in the RC process for formulations containing lignin.
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Appendix A. Appendix
A.1. Flow function
To measure the flowability of powders used in this study, the most
commonly used parameter is flow function (FF) which is defined as
[42, 43]:
FF ¼ MPS=UYS ðA:1Þ
where MPS refers to the major principle stress acting on the powder,
and UYS denotes the unconfined yield strength of the powder at the
MPS. The values for MPS and UYS can be measured by shear cell test
using FT4. The powders are categorised based on the FF values as listed
in Table A.1.
Table A.1
Classification of powders based on FF values.Type of flow Flow function (FF)ee flowing FF N 10
asy flowing 4 b FF b 10
ohesive 2 b FF b 4
ery cohesive and non flowing FF b 2VA.2. Compressibility
Compressibility is a measure of how density changes as a function of
applied normal stress. Indeed, compressibility is the ability of powder to
reduce in volume by applying stress. For powders, the bulk property is
influenced bymany factors such as particle size distribution, cohesivity,
particle shape, and particle surface texture. The standard measurement
method for compressibility of powders utilises a vented piston to
49M. Pishnamazi et al. / Powder Technology 341 (2019) 38–50compress the sample under increasingnormal stress, and the compress-
ibility is calculated using the following equation:
Compressibility
¼ percentage change in volume after compression %ð Þ ðA:2Þ
As we mentioned in the manuscript, the compressibility was mea-
sured by FT4 powder rheometer. For powders, density is a function of
applied normal stress. The changes in density of powders as a function
of applied normal stress are known as compressibility [44]:






Compressibility Index ¼ Density after Compression
Conditioned Bulk Density
ðA:4Þ
The compressibility of powders can be measured by using of Carr's
index and Hausner Ratio [45]:






The range of normal stress was between 1 and 2–4–6–8–10–12–15
kPa.
The Basic Flowability Energy (BFE) value were measured by FT4
powder rheometer for the materials and the results showed that MCC
102 has the highest value of BFE= 177 (MJ), this value indicates that
this material is free-flowing. On the other hand, BFE of lactose was the
lowest BFE= 81.1 mj, it means lactose is more cohesive than other ma-
terials and for Alcell lignin BFE= 119mj.
A.3. Stability index
Stability index is a simple analysis carried out to understand
whether the formulation being analysed changes during the analysis.
It is an indication of the stability of formulation during characterisation.
The stability test runs the formulation through a series of identical mea-
surements, and similar results would be obtained if the formulation
being tested is stable. If the stability index is approximately 1, it
means the powder is physically stable. The SI N 1 or SI b 1 shows unsta-
ble powder. FT4 powder analyser uses the following stability index
formula [46, 47]:
Stability Index; SI ¼ Energy Test 7=Energy Test 1 ðA:7Þ
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Three different methods are considered for tablet manufacturing in
the pharmaceutical industry, i.e. direct compaction, dry, andwet granu-
lation. Recently, there has been focus on direct compaction due to cost
and time effectiveness as less number of processing steps are involved.
Moreover, the tablets produced by direct compaction have faster disso-
lution rates [1]. However, in order to improve powder flowability and
bulk density, especially for poor flowing materials, granulation has
proved useful. Dry granulation is continuous and is the preferred
method for moisture and heat sensitive materials as no binder is used
[2–6].
Today, one of themajor challenges facing the pharmaceutical indus-
try is to enhance the bioavailabilitywhich plays a crucial role in drug de-
velopment [7]. Tablet release rate has a significant effect on tablet
bioavailability [8] inwhich higher release rates result in higher bioavail-
ability and lower side effects. Currently, the most common method for
enhancing the bioavailability of drugs is preparation of amorphous
solid dispersion. In an amorphous solid dispersion (ASD), the API is
transformed to amorphous phase from crystalline by various tech-
niques, and then API is dispersed in a polymeric carrier, which enhances
the dissolution of API molecules.Institute, University of Limerick,Excipients are inert substances used in drug production to assist
manufacturing and control the dosage, quality, stability, bioavailability,
toxicity and efficacy [9–11]. For example, sugar compounds such as lac-
tose and cellulose derivatives such asMCC are themost commonly used
excipients in tablet manufacturing [10,12,13]. In order to investigate
drug release, healing rates, disintegration and dissolution tests have
been extensively studied [14–19]. Several researchers have illustrated
that the influence of excipients on release of oral dosage drugs is signif-
icant [20]. The type of excipient, its physical and chemical properties,
and interaction with API can effect processability and stability of tablets
as well as overcome the drug side effects [21]. Therefore, tablet formu-
lation can be considered as a critical factor in pharmaceutical production
due to its considerable effect on disintegration, dissolution and drug re-
lease rate [7,20,22–24].
Various researchers have focused on improved tablet release rate
and drug absorption, etc. by developing novel excipients. Due to some
issues in relation to side effects and release rates of solid dosage forms
[25], use of materials with desired functionality as excipient in tablets
are increasing. In tabletmanufacturing, amorphousmaterials are show-
ing great promise as excipients as they exhibit higher dissolution com-
pared to crystalline equivalents due to disordered structure and higher
free energy [25–29]. On the other hand, the thermodynamic instability
of amorphous excipients used in tablets, might result in relaxation and
crystal growth of crystalline API molecules over time which is not
favourable for bioavailability [30].
Recently, biological macromolecules have attracted attention for use
as excipient in tablet production to enhance drug dissolution and
Table 1
Characteristics of different formulations used in this study.
Material A B
Acetylsalicylic acid (wt%) 5 5
Alcell lignin (wt%) 20 0
Lactose (wt%) 20 20
MCC 102 (wt%) 51 71
Croscarmellose sodium (wt%) 3 3
Magnesium stearate (wt%) 1 1
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prove chemicalmodification [31–33], and todevelopnewpharmaceutical
formulations with increased functionality [34,35] because of lignin struc-
ture which contains phenolic and aliphatic hydroxyl groups [35]. Lignin
has a high potential to be used in tabletmanufacturing either with chem-
ical modification or without chemical modification [32]. Furthermore,
some researchers have investigated the ability of lignin's nanoparticles
(NPs) in drug delivery due to its non-toxicity, biodegradability and stabil-
ity. Lignin has also been used to transport hydrophobic drugs [35]. Lignin
is an amorphous polymer and non-amphiphilic in nature, and displays
high chemical stability due to 3D network structure [36]. As lignin is
rich in phenolic and aliphatic hydroxyl groups [32], it interacts with
most API molecules through π-π stacking and hydrogen bonding, and
this makes lignin potentially useful as a drug carrier to enhance bioavail-
ability [16,17,21,26,28,34,36,37–41].
Aspirin, which is known as a delayed-release drug is utilised as a
model API in this work [42]. In fact, the dissolution rate of aspirin is
the rate-limiting step, which controls the absorption and bioavailability.
Moreover, another challenge associated with aspirin is that it hydroly-
ses to salicylic acid upon exposure to aqueous solutions, which should
be taken into account during the dissolution tests [8,15,38,42–44].
Wang et al. have investigated aspirin hydrolysis during dissolution
tests, and found out that the hydrolysis of aspirin occurs during dissolu-
tion [44]. Sumirtapura et al. studied the dissolution of different types of
acetylsalicylic acid products, and distinguished time lags for differing as-
pirin tablets [43]. Peltonen et al. utilised three different tablets contain-
ing aspirin for dissolution tests. The first type of tablets contained
aspirin and MCC; the second ones consisted of aspirin and lactose,
while the third ones included aspirin, lactose and MCC. They investi-
gated the effect of pH on aspirin release rate and found higher release
at higher pH. Moreover, they reported that adding lactose to aspirin in
the formulation leads to increased release rate. On the other hand,
adding MCC results in decreased release rate [15].
In comparison with other literature, the authors have tried to ana-
lyse the dissolution of different formulations containing aspirin as API
and various excipients. Lignin was used as a new excipient to evaluate
its performance in tablet manufacturing in order to improve drug re-
lease rates. Indeed, the purpose of this study is to investigate the effect
of Alcell lignin on tablet properties including hardness, disintegration
time and drug release rate. The main aim is to explore the possibility
of using lignin to enhance bioavailability of poorly water-soluble
drugs. Two different formulations are utilised, one formulation contain-
ing Alcell lignin and another one without lignin. First, two different
blends are roller compacted to produce ribbons. Then, the produced rib-
bons are milled to make granules. Afterwards, these granules are used
to produce tablets. Different tablet characterisation tests including; dis-
integration, hardness and dissolution tests are carried out to understand
the effect of lignin on drug release rates.
2. Experimental procedure
2.1. Materials and methods
In order to prepare the formulations, acetylsalicylic acid (Alfa Aesar,
99% C9H8O4) was utilised as a model API. Different excipients were
utilised including microcrystalline cellulose (MCC SANAQ® 102 L USP/
NF/EP), lactose monohydrate (Lennox USP, NF, BP, Ph, pure pharma
grade) and Alcell lignin (Tecnaro (Ilsfeld, Germany)). More details on
the lignin used in this study can be found elsewhere [33]. To prepare
the mixtures, 1% w/w magnesium stearate (Sigma-Aldrich, Ph. Eur.,
BP, ≥90% stearic and palmitic acid basis), as lubricant and croscarmellose
sodium (CCS) (IMCD NF, PH. Eur., JP) as disintegrant were used in the
formulations. Table 1 illustrates the two different formulations consid-
ered; in the first one; 5wt% of aspirinwasmixedwith 20wt% of lactose,
20 wt% of lignin, 3 wt% of CCS and 1 wt%MgSt, and the rest is MCC 102.
The second formulation was prepared with 5 wt% of aspirin, 20 wt% oflactose, 3 wt% of CCS, 1 wt% MgSt, and the rest is MCC 102. All compo-
nents were mixed using a Morphy Richards Stand Mixer. Ortho-
phosphoric acid (analytical reagent grade, Fisher Scientific UK) and ace-
tonitrile, HPLC grade, 99.7 + % min Liquid (Alfa Aesar) were mixed to
prepare mobile phase for HPLC analysis.
2.2. Equipment and instruments
2.2.1. Dry granulation by roll compaction and milling process
To prepare the tablets, the dry granulation method was used for the
entirety of this work in a series of ribbon production, milling, and
tabletting. The ribbonswere produced using a roller compactor (Freund
TF-MINI) integrated with a vertical screw feeder for feeding the formu-
lations. The rollers dimensions are 100 mm in diameter and 25 mm in
width. The considered process parameters included screw speed (SS)
and roll pressure (RP), while roll speed was kept constant at 4 rpm.
The screw speedwas changed between10 and 14 rpm, and roll pressure
was changed between 30 and 50 bars in the ribbon production experi-
ments. The density of produced ribbons was measured using GeoPyc
density analyser (Micrometrics Instrument Corp., Norcross – USA).
The produced ribbonswere thenmilled using a conical mill (Laboratory
Comil 193 AS) with mesh size of 813 μm, and impeller speed of
3000 rpm. The particle size distribution (PSD) of fine powder and gran-
ules were measured using Microtrac S3500 particle size analyser.
2.2.2. Tablet preparation and characterisation
Abenchtop single punch tablet press (Gamlen TabletingGTD-1 D se-
ries) was used to produce the tablets with different formulations.
100 mg of two different formulations of produced granules were
pressed to make tablets in a 6 mm (diameter) die. The tablet compres-
sion was carried out at 180 mm/min speed under fixed load of 400 kg.
Croscarmellose sodium was used as super disintegrant in tablet prepa-
ration experiments [23].
Hardness of the produced tablets wasmeasured using a tablet hard-
ness tester (Pharma Test PTB311E). Tomeasure the disintegration time,
Pharma Test PTZ-DIST- Disintegration Test Instrument (Hainburg,
Germany) was used. The apparatus chamber was filled with 900 mL of
deionized water and the apparatus paddle was adjusted at 100 rpm.
Three samples were tested in deionized water at 37 °C for each process
parameters and for two different formulations. All the disintegration
tests were conducted until the tablets completely disintegrate. The dis-
solution of produced tablets was performed using a Pharma Test PTWS
120D 6-Station Tablet Dissolution Testing Instrument (Hainburg,
Germany).
The concentration of the API in each sample was measured using
High Performance Liquid Chromatography (HPLC). Chromatography
was performed using an Agilent (Agilent Technologies, Waldbronn,
Germany) 1260 Infinity II HPLC system. The HPLC system consisted of
a quaternary pump G1311B, a diode array detector G1315D set at
wavelengths of 200 nm for acetylsalicylic acid and salicylic acid, auto-
sampler G1329 B and a thermostated column compartment G1316A
set at 25 °C. The system operated under isocratic flow at 0.75 mL/min
using mobile phases consisting of A) 0.1% Ortho-phosphoric acid;
B) acetonitrile; A/B = 50/50, v/v. The injection volume was 10 mL.
The total run time was 10 min, and the type of column used was
Kromasil 5C18 (250 × 4.6 mm).
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The dissolution chamber was filled with 500 mL of prepared me-
dium 0.1 N HCl (ACS, ISO, Reag. Ph Eur, Hydrochloric acid fuming
37 wt%) at pH = 1.2. The medium temperature was kept constant at
37 ± 0.5 °C and the stirrer was adjusted to a speed of 75 rpm [42].
When the temperature reached 37 °C, one tabletwas placed in each dis-
solution vessel to run the dissolution test for 120 min. Three millilitres
of the dissolution medium were withdrawn at 5, 10, 20, 30, 40, 50, 60
and 120min, thenmediumwas replacedwith the same amount, imme-
diately. Then, the sampleswere filtered using Captiva Econofilters (PTFE
membrane, 13 mm diameter, 0.2-μm pore size) syringes to prepare for
the analysis byHPLC at 200 nmwavelength, immediately, due to hydro-
lysis of acetylsalicylic acid.
In order to prepare the buffer solution (pH=1.2) for the dissolution
tests, 2 g sodium chloride was dissolved in 200 mL deionized water.
Then, it was diluted with deionized water in a 1000 mL volumetric
flask and 7 mL HCl was added. In order to prepare the calibration solu-
tions for HPLC analysis, 5 mg of acetylsalicylic acid and 5 mg salicylic
acid were dissolved in 20 mL of buffer solution, separately. Then, they
were mixed to prepare the calibration solution. Afterwards, theFig. 1. Dissolution release rate of acetylsalicylic acid for different lprepared solutions were diluted with buffer solution 6 times. The stan-
dard curves of drug concentration vs peak areawere drawn for different
formulations giving R2 = 0.99.
3. Results and discussion
3.1. Dissolution profiles for two different formulations
Two different formulationswere evaluated to find the effect of Alcell
lignin on the aspirin tablet release rate. One formulation contains Alcell
lignin,MCC102 and lactose as excipients and the other one contains lac-
tose and MCC 102 as excipients. Both formulations contain aspirin as
API. Fig. 1 illustrates the graphs of drug release rate for tablets prepared
at various process parameters. As seen, different levels of screw speed
and roll pressurewere considered in this study. Interestingly, the results
show that the tablets containing Alcell lignin have higher release rate
than the tablets without lignin for all prepared samples. In addition,
the equilibrium dissolution for the tablets containing lignin is greater
which is attributed to the enhancement of solubility of ASA with addi-
tion of lignin. It is also seen that faster release kinetics is obtained for
the tablets containing lignin such that the majority of the API areignin and non-lignin tablets at different process parameters.
Fig. 3. Particle size distribution of materials; MCC 102, lactose and lignin.
Fig. 2. Disintegration time of tablets prepared with and without lignin as function of
process parameters.
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prepared with lignin indicated less variability in the dissolution mea-
surements. The data is provided in the Supplementary file for both
formulations.In other words, tablets containing lignin with very high release rate
acts as a disintegrating agent in the dissolution chamber, facilitate the
dissolution kinetics, and accelerate to equilibrium release. Moreover,
due to amorphous nature of lignin, it may be concluded that lignin en-
hances the solubility of API due to its disordered structure and higher
Gibbs free energy of the amorphous phase in the dissolution media.
The cross-linked structure of lignin is likely to have an effect on dissolu-
tion and disintegration as well. Peltonen et al. [15] studied the effect of
pH on the release rate of aspirin tablets with different formulations (B
(aspirin & lactose), A (aspirin, lactose &MCC) and C (aspirin &MCC)).
They illustrated in pH 1.2 the release rate of aspirin with the different
formulations are low and it does not show 100% release rate after
N200 min. Maximum release rates of the formulation B was around
90% after 200 min. For formulation A, the release rate was around 80%
after 500 min and for formulation C was around 70% after 500 min.
The roll compaction process parameters affect the release rate of as-
pirin also in which the effect of roll pressure is more significant com-
pared to screw speed. For the tablets without lignin, increasing roll
pressure (at constant screw speed of 14 rpm) results in reduction of
API dissolution, which could be attributed to the particle size of gran-
ules, which produce the tablets. In the roll compaction process, increas-
ing the roll pressure results in enhancement of granule size. However,
the effect of process parameters on the API dissolution is not significant,
because the dissolution depends mainly on the chemical structure of
API and interaction with the dissolution medium. In fact, the granula-
tion improves the flowability of particles in the manufacturing.3.2. Effect of process parameters on tablet disintegration time
The effect of roll pressure and screw speed as the main process pa-
rameters of dry granulation on the tablet disintegration time for the
two formulations is shown in Fig. 2. In terms of the effect of roll pressure
as process parameter on disintegration time of tablets, the results illus-
trate that increasing the roll pressure while keeping the screw speed
constant, results in decreasing the disintegration time for both formula-
tions. Increasing the roll pressure results in higher densify of ribbons
during the roll compaction process, and subsequently produce larger
granules because higher mechanical energy is required to break up
the ribbons during the milling step. The tablets made with larger gran-
uleswill bemore porous, and subsequently leads to faster disintegration
time. It is also observed from Fig. 2 that the tablets containing lignin
have faster disintegration time than non-lignin tablets due to the amor-
phous and inherent structure of lignin, which has higher affinity to-
wards the solution media compared to MCC and lactose.
Fig. 4. Hardness of tablets prepared with and without lignin as function of process parameters.
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shown in Fig. 3. As observed, lignin has smaller particle size compared
toMCC102, and introducing lignin as an excipient results in better com-
paction behaviour. In fact, smaller particles provide better particle-
particle contact during the roll compaction and denser ribbons are pro-
duced, which in turn results in larger granules in the milling stage [45].
Furthermore, the size distributions of the used granules for tableting are
shown in the Supplementary file. It is seen that the formulation contain-
ing lignin has slightly larger granule size, which results in faster disinte-
gration time.3.3. Effect of process parameters on tablet hardness
Fig. 4 illustrates the hardness of the tablets prepared using the two
formulations as a function of process parameters. The results reveal
that the lignin tablets have higher hardness than non-lignin tablets for
all samples. Also, it can be seen that increasing the roll pressure leads
to reduction of tablet hardness due to larger granules being obtained
at higher roll pressure which in turn leads to weak physical bonds be-
tween particles. The results also indicate that by increasing screw
speed, the tablet hardness decreases; however, the change is not con-
siderable. In addition, the standard range of tablet hardness is between
39 and79N, therefore the lignin tablets arewithin the standard range of
hardness. The reason why tablets containing lignin display higher hard-
ness can be attributed to the interaction between lignin and other con-
stituents of the formulation where lignin acts as a binder thereby
increasing tablet hardness.4. Conclusions
Themain aimof this studywas to investigate the effect of lignin-based
excipients on release of aspirin tablets. Its influence on release rate and
tablet properties at varying processing conditions were assessed. Results
illustrate that lignin tablets, compared to non-lignin tablets, have higher
hardness, faster disintegration time, and higher release rate. Indeed, the
critical quality attributes of the tablets were improved by introducing
the lignin. Higher release rate of tabletswith lignin formulation are are at-
tributed to the amorphous structure of lignin and its interaction with the
API, which presumably improves drug solubility and therefore bioavail-
ability, key factors in oral dosage development. On the other hand, higher
roll pressure leads tomoredensified ribbons associatedwith lignin blends
and consequently, larger granules are produced. These larger granules re-
sult in porous tablets, which lead to faster disintegration times as solute
diffuses faster into the tablets. Also, the greater hardness for the tablets
containing lignin are attributed to better affinity between lignin and
MCC which leads to lignin acting as a tablet binder.
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Abstract Predictive models for simulation of drug
release from tablets containing lignin as excipient
were developed in this work. Two predictive models
including Artificial Neural Network (ANN) and
hybrid ANN-Kriging were developed to simulate the
tablet dissolution. Measured data was collected on the
release rate of aspirin tablets prepared by dry granu-
lation via roll compaction followed by milling and
tableting. Two formulations were considered, one with
lignin and one without. The main aim is to show the
effect of lignin as a bio-based natural polymer in tablet
manufacturing to control drug dissolution. For the
ANN model development, process and formulation
parameters including roll pressure and lignin content
were considered as the input, while API dissolution
was considered as response. The predictions were
compared with measured data to calibrate and validate
the model. To improve the predictability of the model,
Kriging interpolation was used to enhance the number
of training points for the ANN. The interpolated data
was trained and validated. The final concentration and
the dissolution rate were predicted by ANN as well as
ANN-Kriging models, and the R2 of greater than 0.99
for most cases was obtained. The validated model was
used to evaluate the effect of process parameters on the
release rate and it was indicated that the tablets
containing lignin have higher release rate compared to
tablets without. Also, it was revealed that process
parameters do not have significant effect on the tablet
release rate, and the tablet release rate is mainly
affected by the lignin content. The results indicated
that ANN-based model is a powerful tool to predict the
API release rate for tablets containing various formu-
lations, and can be used as a predictive tool for design
of controlled release systems.
Keywords ANN model  Kriging interpolation 
Controlled release  Lignin  Pharmaceuticals 
Tableting  Dry granulation
Introduction
Most drugs are administered in solid phase, such as
crystalline particles which are processed into tablets or
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capsules by adding excipients (Siepmann and Siep-
mann 2013). In pharmaceutical manufacturing of
solid-dosage oral formulations, there are different unit
operations such as blending, granulation, drying,
tableting, and coating among which granulation is
the key processing step as the tablet properties depend
on the granules attributes such as size, API content,
porosity, etc. (Hansuld and Briens 2014; Shirazian
et al. 2018; Suresh et al. 2017; Vervaet and Remon
2005). In granulation processes, pharmaceutical gran-
ules are formed from fine powder (e.g. excipient and
API) using various methods such as roller compaction,
high-shear wet granulation, twin-screw granulation,
fluidised bed granulation, and hot melt extrusion
(Asada et al. 2018; Hansuld and Briens 2014; Ko et al.
2018; Passerini et al. 2010; Walker et al. 2007). The
main reason for granulation is to improve the powder
flowability as well as tablet properties. Among various
granulation processes developed so far, dry granula-
tion is a suitable process for moisture and heat
sensitive formulations, as no binder is used in the
process. Dry granulation is usually carried out using
roller compaction process in which the formulation is
first compacted to produce ribbons, and then granules
are produced by milling the ribbons. The critical
process parameters in roller compaction process
include roll pressure, roll speed, roll gap, and screw
feeder speed (Al-Asady et al. 2015; Omar et al. 2016).
Understanding the relationship between process
parameters of the roll compaction process and tablet
properties is of great importance for development of
pharmaceutical manufacturing and implementing
Quality-by-Design (QbD) approach. The effect of
process parameters and material properties on critical
quality attributes of ribbons and granules have been
reported in literature. Both experimental (Khorasani
et al. 2015, 2016) and theoretical studies (Loreti et al.
2017; Pérez Gago et al. 2016; Reynolds et al. 2010;
Souihi et al. 2015) have been conducted to understand
the roller compaction process. In terms of modelling
studies, Johanson has proven to be a robust and
rigorous mechanistic model for better understanding
of roller compaction process (Reynolds et al. 2010).
Although, previous studies reveal the correlation
between critical process parameters and granules/
ribbons properties in roller compactor processes
(Pishnamazi et al. 2019a), understanding the relation-
ship between process parameters and tablet dissolution
still remains a challenge and opportunities arise in
helping to improve tablet dissolution rate by tuning
formulation and process parameters.
Drug dissolution is an important quality attribute of
pharmaceutical tablets in which the kinetics and
equilibrium concentration (solubility) of Active Phar-
maceutical Ingredient (API) release from the tablets is
of utmost importance (Siepmann and Siepmann 2013).
The main focus of controlled release systems is to
manipulate the release rate of APIs through different
techniques such as incorporating into polymeric
matrix (Castro-Dominguez et al. 2017), and loading
drug in stimuli-responsive nanocarriers (Fleige et al.
2012), and therefore enhancing bioavailability for
poorly water soluble APIs. Nowadays, a big challenge
facing the pharma industry is poor solubility of newly
produced drugs in the body, i.e. bioavailability.
According to Biopharmaceutics Classification Sys-
tem, BCS Class II and BCS Class IVmany drugs are of
poor solubility and bioavailability (Daousani and
Macheras 2016). It has been recognised that seven
out of ten of drugs never reach the patients. Develop-
ment of solid dispersions have been reported to be
effective in improving the solubility of BCS Class II
drugs (Van den Mooter 2012). Amorphous solid
dispersions provide high dissolution rates because of
their disordered structure and higher Gibbs free energy
compared to crystalline APIs (Ziaee et al. 2017).
Recently, lignin has attracted much attention as it
may be used to improve the release of bio-active
compounds (Chowdhury 2014; Collins et al. 2019).
Lignin is a cross-linked natural polymer, cheap, and
available (Culebras et al. 2018). Due to amorphous
nature of lignin which has higher free energy, it can be
used as modifier to enhance the bioavailability of
poorly soluble APIs. However, understanding the
effect of lignin on dry granulation using roller
compactor, and finding a correlation between lignin
content and tablet dissolution rate remains a big
challenge. Developing a robust predictive model for
designing controlled release systems based on natural
polymers is of great importance for pharmaceutical
industry.
Therefore, there is a definite need for a compre-
hensive study to correlate the critical process param-
eters of roller compactor as well as formulation with
tablet dissolution as the key critical quality attribute. A
powerful tool is the development of a process model
where inputs and outputs can be correlated. Different
models have been used for pharmaceutical
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manufacture such as mechanistic models (Sajjia et al.
2017; Shirazian et al. 2018) and soft computing
approaches (Mustafa et al. 2017; Shirazian et al.
2017). Artificial Neural Network (ANN) is a soft
computing method which is capable of predicting the
process and making correlation between process
inputs and outputs (Ismail et al., 2019a, b). Applica-
bility, robustness, and reliability of ANN in pharma-
ceuticals have been verified in the literature (Das and
Chakraborty 2016; Mustafa et al. 2017; Shirazian et al.
2017).
The main objective of the current study is the
development of a comprehensive ANN-based model
for prediction of dissolution rate of tablets prepared by
roller compaction followed by milling and tableting.
In order to enhance the bioavailability of API, lignin is
used as excipient and the tablet dissolution rate is
measured for tablets containing lignin and without
lignin. Aspirin is used as model API in this study.
Experiments
Materials and methods
Two different formulations containing API and excip-
ients were considered in this study for preparation of
tablets. The excipients used include microcrystalline
cellulose (MCC 102, SANAQ), lactose monohydrate
(Lennox USP, NF, BP, Ph, pure pharma grade), and
Alcell lignin (Tecnaro, Germany). More details on the
lignin used in this study can be found elsewhere
(Culebras et al. 2018). Acetylsalicylic acid (Alfa
Aesar, 99% C9H8O4) was utilised as API in both
formulations. Magnesium stearate (Sigma-Aldrich,
Ph. Eur., BP, C 90%) was used as lubricant for the
compaction experiments, and Croscarmellose sodium
(CCS) (IMCD NF, PH.Eur., JP) was used as disinte-
grant in both formulations. The percentage of the
materials used in two different formulations are listed
in Table 1. To prepare the mixture, all the materials
were blended using a Morphy Richards Stand Mixer.
HCl acid (ACS, ISO, Reag. Ph Eur, Hydrochloric acid
fuming 37%) was used for preparation of buffer
solutions for dissolution tests. For preparation of the
mobile phase for analysing the API concentration with
HPLC, Ortho-phosphoric acid (analytical reagent
grade, Fisher Scientific UK) and acetonitrile, HPLC
grade, 99.7 ? %min Liquid (Alfa Aesar) were mixed
together.
Equipment and instruments
Dry granulation method was utilised to produce the
tablets for two different formulations. In order to do
dry granulation process, roller compaction was carried
out. The roller compactor, (‘‘Freund TF-MINI’’), with
roll diameter of 100 mm and width of 25 mm
integrated with a vertical screw feeder was used to
produce ribbons. The roll pressure was changed
between 30 and 50 bar in the experiments. A conical
mill (Laboratory Comil 193 AS) with a screen (mesh
size of 813 lm) and impeller speed of 3000 rpm was
used to produce the granules from the ribbons. The
considered process parameters included screw speed
(SS) and roll pressure (RP), while roll speed was kept
constant at 4 rpm. The screw speed was changed
between 10 and 14 rpm, and roll pressure was changed
between 30 and 50 bars in the ribbon production
experiments.
For tableting process, a single punch tablet press
(Gamlen Tableting GTD-1 D series) was applied. For
preparation of each tablet, 100 mg of granules of each
formulations were measured and compacted to pro-
duce tablets in a 6 mm die. The tablet compression
was carried out at 180 mm/min speed under fixed load
of 400 kg.
Dissolution procedure
For the dissolution analysis, buffer solution at pH =
1.2, including 0.1 N HCl (ACS, ISO, Reag. Ph Eur,
Hydrochloric acid fuming 37% wt.) was prepared as
dissolution medium. 500 ml of the dissolution test
chamber was filled with the buffer solution, with the
Table 1 Different formulations used in this work
Material (% w/w) Formulation 1 Formulation 2
Acetylsalicylic acid 5 5
Alcell lignin 20 0
Lactose 20 20
MCC 102 51 71
Croscarmellose sodium 3 3
Magnesium stearate 1 1
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constant temperature at 37 ± 0.5 C and 75 rpm
stirrer speed. The experiment was run for 120 min,
and the samples (Three mL) were withdrawn from the
dissolution chamber at 5, 10, 20, 30, 40, 50, 60,
120 min. Afterward, the samples were filtered and the
concentration of API was measured using HPLC at
wavelength of 200 nm. The dissolution tests were
carried out in triplicate, and the average values were
used for modeling.
High-Performance Liquid Chromatography
(HPLC) was used to measure the API concentration
in each samples via an Agilent (Agilent Technologies,
Waldbronn, Germany) 1260 Infinity II HPLC system.
The HPLC setup consisted of a quaternary pump
G1311B, a diode array detector G1315D set at
wavelengths of 200 nm for acetylsalicylic acid, auto-
sampler G1329 B and a thermostated column com-
partment G1316A set at temperature of 25 C. The
system operated under isocratic flow at 0.75 mL/min
using mobile phases consisting of A) 0.1% Ortho-
phosphoric acid; B) acetonitrile; A/B = 50/50, v/v.
The injection volume was 10 mL. The total run time
was 10 min, and the type of column used was




In order to develop a predictive model, artificial neural
network (ANN) approach was used in which the
process parameters and material properties are corre-
lated with critical quality attributes. Roll pressure,
screw speed, and lignin content in the formulation
were considered as the inputs, whereas the kinetics and
final API dissolution were considered as outputs for
developing ANN. The preliminary results indicated
that screw speed has negligible effects on the quality
attributes of ribbons, therefore, screw speed was
omitted from the process parameters. An ANN model
consisting of two hidden layers was developed as
shown in Fig. 1. JMP Pro 14 software was used for
developing the ANN model and analysing the results.
To find the optimum ANN structure, different
transfer functions were tested, and the best results
were obtained for the structure consisting of 6 non-
liner (hyperbolic tangent), 2 liners, and 2 Gaussian
functions in the first layer; with 6 non-linear nodes for
the second layer (see Fig. 1). In ANN modelling using
JMP, the linear combination of input variables (roll
pressure and lignin content) are not transformed when
using the linear activation function, while for the non-
linear function, the hyperbolic tangent term is used as
follows (SAS_Institute 2016; Shirazian et al. 2017):
e2z  1
e2z þ 1 ð1Þ
where z is a linear combination of input variables.
In order to build ANN model, 60% of the measured
data was used to train the network, while 40% was
used for model validation and testing the developed
model in prediction of the API release rate. The
network was trained to predict the concentration of
API at different sampling time intervals, as function of
lignin content and roll pressure of roller compactor.
The developed ANN model was used for prediction of
API release rate, in which the predictive behaviour and
accuracy of the model is assessed by comparing the
predicted values and the measured values. The coef-
ficient of determination (R2) which indicates the
goodness of fitting is calculated as (Barrasso et al.
2015; Shirazian et al. 2017):
R2 ¼ 1
P
i fi  yið Þ2P
i yi  yið Þ2
ð2Þ
where f refers to the predicted points, and y refers to
the observed values. i denotes the set of experimental









where n denotes the number of measurements.
ANN-Kriging hybrid model
In order to improve the predictability of the developed
ANNmodel for API dissolution, Kriging interpolation
method was used to enhance the number of training
and validating points for the ANN. Ordinary Kriging
interpolation was developed based on two inputs and
eight outputs which are the dissolution percentage at
various times. Kriging method predicts a response yk
at an interpolated point xk as a weighted sum of the
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observed responses (y1, y2…yn) where xk falls in the
neighbourhood of their corresponding sampling points
(x1, x2, x3…xn) (Boukouvala et al. 2011):
yk ¼ f xkð Þ ¼
Xn
i¼1
wif xið Þ ð4Þ
wi is the weighted sum (kriging weights) which
depends on the Euclidian distance h:





In Kriging algorithm, the main objective is to
calculate the set of Kriging weights assigned to each
group of n clustered points in the neighbourhood of xk
where the derived variogram model leads the sum of
the weights to unity. In calculating the interpolated
prediction f xkð Þ at xk, the observed responses (y1,
y2…yn) for sampled points (x1, x2, x3…xn) that are in
the neighbourhood and nearer to xk will have more
influence on predicting f xkð Þ. Indeed, the higher
number of neighbouring points and the nearer these
neighbouring points are to xk, f xkð Þ will be calculated
with more confidence (Ismail et al., 2019a, b).
In ordinary kriging interpolation, the experimental
variogram is calculated from the experimental data
points to statistically quantify the dataset in a form that
fits statistical equations (exponential, Gaussian, cubi-
c…etc.). After fitting the experimental and theoretical
variograms, kriging weights are then calculated to
determine the interpolated response.
A two-dimensional kriging interpolation was con-
ducted on the experimental data obtained from the
dissolution experiments to predict the dissolution of
API at new data points. The reliability and validity of
the hybrid ANN-kriging has been proved in our
previous works (Ismail et al., 2019a, b). Ordinary
Kriging interpolation was performed inMatlab where
the lignin content (%) and roller pressure (bar) were
taken as input parameters and API dissolution at 5, 10,
20, 30, 40, 50, 60 and 120 min as output parameters.
Fig. 1 Structure of
developed ANN for
prediction of drug release
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Interpolation was conducted at 10 new points for each
dimension in which 121 points were obtained after
applying Kriging. The interpolated kriging data was
used to improve the empirical ANN model prediction
compared to using just experimental data.
The structure of the developed ANN-Kriging is
shown in Fig. 2. As seen, the hybrid model contains
two hidden layers, each layer constitutes of three
nodes which makes the model simpler and faster to
solve. Also, a combination of linear and nonlinear
transfer functions has been used for the hybrid model
to train the network for prediction of data.
Results and discussion
ANN model
The developed ANN model was first trained using the
experimental data collected on the release rate of
tablets containing aspirin. The trained network was
then used to validate the model. The results of training
and validation are listed in Table 2 for the concentra-
tion of API at different times, and the final concen-
tration of API at the time of 120 min (final). As seen,
the model is very well trained with the experimental
data, and the R2 of 1 is obtained for all points, while for
the validation R2 of 0.99 is obtained for most cases
except for predicting the concentration of API after
5 min which could be attributed to high release rate at
the beginning of the dissolution test. It is clearly
observed that the model can predict the release rate of
API with high accuracy, and can be used as a powerful
predictive tool for the design of release systems based
on lignin. However, it should be pointed out that there
might be a risk of over-prediction in this system as
small number of experimental points are used. There-
fore, Kriging approach was used to train the network
for more data points and prevent the risk of over-
prediction.
ANN-Kriging model
The predicted release rate versus the measured values
for both training and validation for the hybrid ANN-
Kriging model are depicted in Fig. 3. Moreover, the
statistical data of the calibration and validation for the
hybrid ANN-Kriging is listed in Table 3. After
Kriging, the number of data points are increased to
121 points to make a more robust predictive model.
Fig. 2 Structure of
developed ANN-Kriging
hybrid model for prediction
of drug release
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1/3 of the data points were used for validation, while
2/3 were used for training the network. It is clearly
seen that the model is well trained for all the training
points and the cross validation can confirm the model
can be used for prediction of the dissolution. Also,
similar to the ANN model, some deviations are
observed for the dissolution data after 5 min, however
R2 has been significantly improved for 5 min data
from 0.52 to 0.67 for the validation stage.
Simulation of the release rate using ANN model
The validated model was used to simulate the release
rate of API for the tablets prepared with two formu-
lations. The experimental and predicted release rates
for the tablet without lignin, and the tablets containing
lignin are represented in Figs. 4 and 5, respectively.
The graphs of release rate indicate that the release rate
is very high at the beginning of dissolution test, and
more than 60% of the API is released after 5 min.
After 20 min, the drug concentration in the solution
reaches the highest values, and then decreases, and
finally become plateau which is considered as the
equilibrium point. The reason for reduction in the
concentration of API after 20 min could be attributed
to the dissociation of aspirin which undergoes hydrol-
ysis during the dissolution test. Aspirin is partially
hydrolysed to salicylic acid and acetyl salicylic acid
upon exposure to aqueous solutions (Pishnamazi et al.
2019b).
It is also observed in Figs. 4 and 5 that the release
rate of aspirin is higher in the tablets containing lignin
such that higher dissolution rate is observed in the
dissolution test of tablets containing lignin. This could
be due to amorphous nature of lignin which enhances
the dissolution of aspirin. It is observed that the model
is robust and can predict the release rate and the final
concentration as well.
Design space for the API release
The developed model was used to understand the
effect of process parameters of roll compaction as well
as formulation on the release rate of API. In roller
compaction process, roll pressure is the most impor-
tant parameter compared to other parameters such as
screw speed and roll speed (Pishnamazi et al. 2019a).
The effect of roll pressure and lignin content on the
equilibrium concentration of API in the buffer solution
is shown in Fig. 6. The roll pressure was considered
between 30 and 50 bar, and the lignin content between
0 and 20 wt%. It is indicated that by increasing the
lignin content in the formulation, the dissolution of
API increases significantly which consequently can
Table 2 Statistical data of ANN calibration and validation
Times (min) Data set R2 RMSE Mean Abs Dev -LogLikelihood SSE Data points
5 Training 1 8.7e-13 7.5e-13 - 105.4 3.0e-24 4
Validation 0.52 2.6 1.9 4.8 14.0 2
10 Training 1 2.1e-13 1.8e-13 - 110.9 1.9e-25 4
Validation 0.99 0.2 0.2 - 0.2 0.1 2
20 Training 1 3.7e-13 3.2e-13 - 108.8 5.6e-25 4
Validation 0.99 0.5 0.4 1.5 0.5 2
30 Training 1 4.3e-13 3.7e-13 - 108.2 7.3e-25 4
Validation 0.99 0.6 0.6 1.7 0.6 2
40 Training 1 4.3e-13 3.7e-13 - 108.2 7.5e-25 4
Validation 0.99 0.4 0.4 1.1 0.4 2
50 Training 1 2.9e-13 2.4e-13 - 109.8 3.3e-25 4
Validation 0.91 1.5 1.4 3.7 4.7 2
60 Training 1 4.1e-13 3.5e-13 - 108.4 6.7e-25 4
Validation 0.99 0.1 0.1 - 0.9 0.04 2
120 Training 1 4.0e-13 3.3e-13 - 108.5 6.4e-25 4
Validation 0.99 0.3 0.3 0.6 0.2 2
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enhance the bioavailability of API. Also, it is seen that
by increasing the pressure, the dissolution decreases,
however the effect of roll pressure on the dissolution is
not significant compared to the effect of lignin content
because the dissolution of API is highly dependent on
the chemistry of formulation and the dissolution
medium. It is observed that increasing roll pressure
decreases the equilibrium concentration of API which
is attributed to the size of granules. As the roll pressure
increases, denser ribbons are produced, which results
in formation of larger granules in the milling step.
Larger granules in the prepared tablets results in lower
Fig. 3 Actual versus predicted values of drug release for the hybrid ANN-Kriging model
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dissolution as the surface area of the granules
decreases and reduce the surface energy and
dissolution.
Conclusions
A new formulation containing lignin was designed in
this work to enhance the bioavailability of drugs. The
tablets were prepared using dry granulation method
followed by milling and tableting. In order to design
and predict the release rate of API, an artificial neural
Fig. 3 continued
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Table 3 Statistical data of hybrid ANN-Kriging calibration and validation
Times (min) Data set R2 RMSE Mean Abs Dev -LogLikelihood SSE Data points
5 Training 0.69 0.98 0.68 135.83 93.45 97
Validation 0.67 0.89 0.71 31.15 18.84 24
10 Training 0.99 0.34 0.27 32.50 11.10 97
Validation 0.99 0.30 0.26 5.54 2.23 24
20 Training 0.99 0.13 0.09 - 60.92 1.62 97
Validation 0.99 0.14 0.10 - 12.88 0.48 24
30 Training 0.99 0.07 0.05 - 113.76 0.54 97
Validation 0.99 0.07 0.06 - 27.58 0.14 24
40 Training 0.99 0.07 0.057 - 116.05 0.52 97
Validation 0.99 0.07 0.05 - 27.56 0.14 24
50 Training 0.99 0.10 0.07 - 83.30 1.02 97
Validation 0.99 0.12 0.08 - 16.13 0.36 24
60 Training 0.99 0.06 0.05 - 133.06 0.36 97
Validation 0.99 0.06 0.05 - 31.47 0.10 24
120 Training 0.99 0.07 0.05 - 120.85 0.47 97
Validation 0.99 0.07 0.05 - 29.28 0.12 24
Fig. 3 continued
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network (ANN)model was developed considering two
hidden layers and combining various activation func-
tions, i.e. linear, hyperbolic tangent, and Gaussian.
The ANN model as well as hybrid ANN-Kriging were
developed to predict the dissolution of the drug. Two
formulations, one containing lignin, and the other one
without lignin were considered to investigate the
effect of lignin on the API release rate. The results of
release rate indicated that the tablets containing lignin
have higher release rates of API. The results of
simulation revealed that the developed model can
predict the release rate with high accuracy and
R2= 0.99 was obtained for most cases. The model
was used to predict the kinetics and equilibrium of the
release rate and great agreement was obtained between
the predicted and measured data. The validated model
was then used to understand the effect of process
parameters on the release rate, and it was revealed that
increasing roll pressure decreases the release rate,
because larger granules are produced which in turn
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Passerini N, Calogerà G, Albertini B, Rodriguez L (2010) Melt
granulation of pharmaceutical powders: a comparison of
high-shear mixer and fluidised bed processes. Int J Pharm
391:177–186
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Abstract: The influence of lignin modification on drug release and pH-dependent releasing behavior
of oral solid dosage forms was investigated using three different formulations. The first formulation
contains microcrystalline cellulose (MCC 101) as the excipient and paracetamol as the active
pharmaceutical ingredient (API). The second formulation includes Alcell lignin and MCC 101
as the excipient and paracetamol, and the third formulation consists of carboxylated Alcell lignin,
MCC 101 and paracetamol. Direct compaction was carried out in order to prepare the tablets. Lignin
can be readily chemically modified due to the existence of different functional groups in its structure.
The focus of this investigation is on lignin carboxylation and its influence on paracetamol control
release behavior at varying pH. Results suggest that carboxylated lignin tablets had the highest drug
release, which is linked to their faster disintegration and lower tablet hardness.
Keywords: lignin; drug release; paracetamol; disintegration
1. Introduction
Excipients play a significant role in the final product of pharmaceutical solid dosage forms.
Variations in excipient properties influence tablet processability, hardness, disintegration and
bioavailability [1–3]. Nowadays, many researchers have focused their investigations on using
natural biopolymers [4] in tablet manufacturing due to their biocompatibility [5,6]; they are also cheap
and widely available [7–9]. Lignin is a natural biopolymer with a number of beneficial properties
including biodegradability and biocompatibility [10–14]. Recently, the use of lignin is increasing as
a sustainable polymer for preparing carbon fibers [15], biofuels, bioplastics and controlled release
carriers [16–21]. Due to the existence of different functional groups in the lignin structure such as
phenolic, hydroxyl and carboxyl groups, lignin can be chemically modified to enhance drug delivery
and to control drug release [22–24]. Figueiredo et al. functionalized Kraft lignin nanoparticles by
carboxylation in order to improve drug delivery of poorly water-soluble anti-cancer drugs which were
pH-sensitive [18]. Lievonen et al. modified softwood Kraft lignin using a dialysis technique to improve
its drug delivery performance [25]. Furthermore, it has been recognized that pH-responsive drug
carriers provide superior drug delivery characteristics due to their ability to increase the stability of the
active pharmaceutical ingredient (API) molecules in the stomach and release the API in the intestine [26].
Li et al. investigated the release behavior of ibuprofen using lignin-based complex micelles. The results
of release tests illustrated pH-dependent and controlled release properties due to ionization of the
Polymers 2019, 11, 1059; doi:10.3390/polym11061059 www.mdpi.com/journal/polymers
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carboxyl groups in the lignin structure, with repulsive forces between the negatively-charged carboxyl
groups of lignin and the API molecules, with higher solubility of the API at pH = 7.4 [27]. Chen et al.
synthesized lignin-based pH-responsive nano-capsules to improve the controlled release of poorly
water-soluble drugs by varying pH [28]. Duval et al. studied pH and light responsive behavior of
controlled-release systems containing diazobenzen and modified softwood Kraft lignin [29]. Various
investigations have been carried out on the effect of lignin-based polymeric nanoparticles (NPs) on the
controlled release of pesticides [30,31].
Bulut et al. studied the controlled-release behavior of paracetamol using chitosan-graft-polyacrylamide
microspheres via an emulsion crosslinking technique [32]. They utilized glutaraldehyde (GA) as a
crosslinker to investigate its effect on the drug release rate. They mentioned the drug release rate was
affected by some parameters such as the amount of GA, copolymer concentration and the composition
of the drug and polymer. Their results illustrated that more controlled release of the drug occurred
by increasing the GA amount and copolymer and decreasing the composition (paracetamol/polymer)
ratio. Treenate et al. investigated the controlled release properties of paracetamol using a novel system
composed of hydroxyethylacryl chitosan and sodium alginate in order to improve drug delivery for
oral dosage forms [33]. Through improving drug water solubility, drug efficiency will be improved [34].
The current authors have evaluated the effect of lignin on the release rate of aspirin in oral dosage form,
and indicated the higher release rate of drugs using lignin as an excipient in tablet formulation [9].
In this study, the effect of carboxylated lignin as an excipient on paracetamol release behavior
was investigated. Lignin carboxylation was performed to enhance the carboxyl group content on
the lignin surface in order to increase the interactions between the lignin and paracetamol functional
groups and allow pH triggered release. To the best of our knowledge, no studies have reported the
use of carboxylated lignin in paracetamol tablet manufacturing and its effect on the release. Three
different formulations have been considered, one without lignin, one using pure lignin and one with
carboxylated lignin. Paracetamol is utilized as a model drug in this research; it is a nonsteroidal
anti-inflammatory [35]. Paracetamol is widely used as a pain relief drug as it has fast absorption
within the small intestine of the human body [36,37]. Tablets were prepared by direct compaction
and characterized using disintegration and dissolution tests. Modified lignin was verified using
Fourier-transform infrared spectroscopy (FTIR). Drug release rates were measured using dissolution
tests at pH 5.8 according to the United States Pharmacopeia (USP) [38]. In order to investigate the
controlled release behavior of paracetamol, dissolution tests were carried out at acidic conditions
(pH 1.2) and phosphate (pH 7.2) buffer solutions.
2. Experiments
2.1. Materials and Methods
Paracetamol (4-acetamidophenol, Phion) was used as a model API to prepare three different
formulations. Microcrystalline cellulose (MCC SANAQ®101 L USP/NF/EP) and Alcell lignin (Tecnaro,
Ilsfeld, Germany) were used as excipients. More details on the lignin used in this study can be found
elsewhere [2,15]. Table 1 shows the composition of the three formulations considered.




Paracetamol (wt %) 20 20 20
Alcell lignin (wt %) 0 10 0
Modified Alcell lignin (wt %) 0 0 10
MCC 101 (wt %) 80 70 70
MCC = microcrystalline cellulose.
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2.2. Lignin Modification
In order to allow conjugation reactions between lignin and paracetamol, lignin is functionalized
with carboxylic acid groups. Synthesis of COOH–lignin involves a ring-opening reaction of succinic
anhydride with 4-dimethylaminopyridine (DMAP). Lignin (2 g), succinic anhydride (2 g) and DMAP
(400 mg) were added to 250 mL of tetrahydrofuran (THF) in a 500 mL round-bottom flask, followed
by stirring for 48 h at room temperature [18]. The obtained carboxyl functionalized precipitate was
filtered, and then, washed for 24 h using deionized water via the Soxhlet extraction system in order to
remove the unreacted reagents. Finally, the modified lignin was placed in a freeze-dryer overnight.
The proposed mechanism pathway [18] is presented in Figure 1.
Polymers 2019, 11, x FOR PEER REVIEW 3 of 10 
 
In order to allow conjugation reactions between lignin and paracetamol, lignin is functionalized 
with carboxylic acid groups. Synthesis of COOH–lignin involves a ring-opening reaction of succinic 
anhydride with 4-dimethylaminopyridine (DMAP). Lignin (2 g), succinic anhydride (2 g) and DMAP 
(400 mg) were added to 250 mL of tetrahydrofuran (THF) in a 500 mL round-bottom flask, followed 
by stirring for 48 h at room temperature [18]. The obtained carboxyl functionalized precipitate was 
filtered, and then, washed for 24 h using deionized water via the Soxhlet extraction system in order 
to remove the unreacted reagents. Finally, the modified l i  was placed in a freez -dryer overnight. 
The proposed mechanism pathway [18] is prese t   Figure 1. 
 
Figure 1. Mechanism of lignin carboxylation. 
2.3. Tablet Preparation 
In order to prepare the tablets, a single-punch tablet press (Gamlen Tableting GTD-1 D series) 
was utilized. Each formulation (100 mg) was compacted to make each tablet in a 6 mm die. The tablet 
load was set at 400 kg, with a compaction rate of 180 mm/min. 
2.4. Characterisation 
Fourier-transform infrared spectroscopy (FTIR) measurements was carried out utilizing a 
Nicolet Nexus FTIR spectrometer between 450–4000 cm−1 equipped with an attenuated total 
reflectance accessory (ATR). A total of 60 scans were performed with a spectral resolution of 2 cm−1. 
Tablet hardness was measured using a tablet hardness tester (Pharma Test PTB311E). Pharma Test 
PTZ-DIST-Disintegration Test Instrument (Hainburg, Germany) was used to measure the tablet 
disintegration time. Deionized water (900 mL) was used to fill out the apparatus vessel and the 
peddle speed was kept constant at 100 rpm. The temperature of the vessel was adjusted to 37 °C. The 
tests were performed for the two formulations containing pure lignin and carboxylated lignin until 
the tablets completely disintegrated. A Pharma Test PTWS 120D 6-Station Tablet Dissolution Testing 
Instrument (Hainburg, Germany) was utilized to analyze the dissolution rate of the tablets. For the 
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2.3. Tablet Prepa ation
In order to prepare the tablets, a single-punch tablet press (Gamlen Tableting -1 series) was
utilized. Each formulation (100 mg) was compacted to make each tablet in a 6 mm die. The tablet load
was set at 400 kg, with a compaction rate of 180 mm/min.
2.4. Characterisation
Fourier-transform infrared spectroscopy (FTIR) measurements was carried out utilizing a
Nicolet Nexus FTIR spectrometer between 450–4000 cm−1 equipped with an attenuated total
reflectance accessory (ATR). A total of 60 scans were performed with a spectral resolution of 2 cm−1.
Tablet hardness was measured using a tablet hardness t ster (Pharma Test PTB311E). Ph rma Test
PTZ-DIST-Dis ntegration Test Instrument (Hainburg, Germany) was used o m asure the tablet
disintegration time. Deionized water (900 L) was used to fill out the apparatus vessel and the peddle
speed was kept constant at 100 rpm. The temperature of the vessel was adjusted to 37 ◦C. The tests were
performed for the two formulations containing pure lignin and carboxylated lignin until the tablets
completely disintegrated. A Pharma Test PTWS 120D 6-Station Tablet Dissolution Testing Instrument
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(Hainburg, Germany) was utilized to analyze the dissolution rate of the tablets. For the measurement
of drug concentration, a Cary 60 UV Spectrophotometer (Agilent Technologies, Waldbronn, Germany)
was used at a wavelength of 249 nm. All tests were carried out in triplicate. The calibration graph can
be found in the Supplementary Information.
2.5. Dissolution Test Procedure
Phosphate buffer with pH = 5.8 (according to USP 23) was used as the dissolution medium [38,39];
900 mL of medium was prepared to fill each dissolution vessel. The temperature of the medium
chamber and the stirrer speed were kept constant at 37 ± 0.5 ◦C and 50 rpm, respectively. When
running the dissolution test, first, the temperature should reach 37 ◦C. For each run, three vessels were
utilized, and one tablet was considered for each vessel. Five milliliters of sample was withdrawn at
5 min, 10 min, 20 min, 30 min, 40 min, 50 min, 60 min and 120 min from each vessel and the same
amount of medium was supplant, instantly. Afterwards, the samples were filtered by applying a
Captiva Econofilter (PTFE membrane, 13 mm diameter, 0.2-µm pore size). Eventually, all samples
were analyzed to measure the drug concentration using a Cary 60 UV Spectrophotometer at 249 nm
wavelength, which was calibrated to the optimal wavelength. The cuvette type was 1/Q/10, quartz
with pathway of 1 cm. In order to minimize the statistical error, all experiments were done in triplicate.
For the dissolution tests of pH-responsive analysis, due to the evaluation of the controlled release
behavior of paracetamol in the carboxylated lignin formulation, two different pHs were considered:
phosphate buffer solution, pH = 7.2 (intestine environment) and acidic buffer solution (0.1 N HCL),
pH = 1.2 (gastric environment) [40,41].
3. Results and Discussion
3.1. FTIR Characterization of Pure Lignin and Modified Lignin
The FTIR spectra analysis was carried out to monitor the pure lignin structure and to characterize
the chemical changes in the functional groups of the lignin structure during the carboxylation reactions.
Figure 2 shows the spectra of pure lignin and functionalized lignin, which have similar peaks, such as
C=O (carbonyl groups) at 1600 cm−1, –OH (hydroxyl groups) which are attributed to the phenol and
alcohol in the region of 3600–3100 cm−1 and an aromatic ring region at 1425–1514 cm−1. Nevertheless,
the hydrogen-bonded hydroxyl stretching band of carboxylic acid (2250–3600 cm−1) and the stretching
vibrations of C=O of the unconjugated –COOH groups at 1720 cm−1 exhibit a stronger absorption
bond than the pure lignin (unmodified), proving that grafting lignin with carboxylic acid groups has
been successfully done.
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3.2. Effect of Lignin Carboxylation on Tablet Disintegration Time
Tablet disintegration time affects the tablet dissolution and can be used as a valuable test for solid
oral dosage forms. Tablet hardness can influence tablet disintegration time, with higher hardness
leading to longer disintegration times [42,43]. In order to study the effect of lignin carboxylation
on the tablet disintegration time, a disintegration test was performed for the three different tablets
(non-lignin, pure lignin and modified lignin). Figure 3 presents the disintegration time results in
which a faster disintegration time for tablets containing modified lignin is obtained. Moreover, tablet
hardness is measured using a hardness tester (Pharma Test, PTB) for three formulations, and the results
show higher hardness for the formulation without lignin (Figure 4). Tablet hardness is affected by
the physical properties of materials and the interaction of the drug with the excipient. The tableting
method is the same for each formulation in order to mitigate its influence on tablet hardness. Generally,
lower hardness equals to higher porosity; therefore, the lower hardness and higher porosity of the
carboxylated lignin tablet is due presumably to the structural differences in lignin after modification.
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3.3. Effect of Lignin Carboxylation on Drug Release Rate
Dissolution tests were performed to evaluate the effect of lignin and carboxylated lignin on
the paracetamol tablet release rate. The three different formulations in Table 1 were considered to
study paracetamol release rate in phosphate buffer solution at pH 5.8, according to the USP [38]. The
release rate graphs of three different batches of paracetamol are displayed in Figure 5. Although the
drug dissolution release is more dependent on the disintegration time, the formulation and material
properties can influence the drug release rate. For this case, the graphs illustrate that the tablets
containing functionalized lignin have the highest drug release rate and this correlates with the fastest
disintegration time of these formulations and the lowest tablet hardness.
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r er, the prepared tablets containing pure ligni have a higher drug release rate compared to
the formulation without lignin due to faster disintegration and lower tablet hardness [9]. Thus, lignin
functionalization improved the release prop rties of directly compa ted racetamol tablets.
3.4. Controlled Release and pH-Responsive Behavior of Carboxylated Lignin
Drug release rate was studied in our previous work by adding lignin to the formulation [9].
The results revealed a higher drug release rate for the formulation containing lignin because of the
amorphous structure of lignin and the interaction between lignin and the API, which resulted in
an improvement in drug dissolution, which is the key factor in oral dosage development. Thus,
for the present study, we have focused on drug controlled-release. The pH-responsive behavior
of carboxylated lignin was investigated using dissolution tests in different media at various pH
values: 0.1 M HCl solution (pH of 1.2, gastric environment) and phosphate buffer (pH 7.2, intestine
environment) at 37 ◦C. The dissolution graphs in Figure 6 show a greater release rate of the drug in
the buffer with pH = 7.2 [40]. Increasing the carboxyl groups results in an increase in drug release at
pH = 7.2 compared to pH = 1.2. At pH = 1.2, the electrostatic repulsion between the lignin carboxyl
groups decreases due to the protonation of carboxyl groups at lower pH values. However, at pH = 7.2,
due to ionization of the carboxyl groups (pKa = 4.8) of modified lignin, the negatively-charged ions
repel each other and presumably this leads to a swelling effect (similar to how hydrogels swell upon
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ionization [44]) and this results in higher release rates of the API. The results of this work reveal
that lignin is a promising compound for use in controlled-release systems and also for enhancing the
solubility of active pharmaceutical ingredients. This is the first time that modified lignin was used for
the controlled-release of paracetamol. This could be very interesting from the point of view of lignin
valorization since, at the moment, the market for high value applications is very limited. The use
of lignin in the pharmaceutical industry can lead to the development of new value chains for lignin
promoting circular bio-economy.
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4. Conclusions
The ai of this study as to evaluate the p -dependent release behaviors of odified lignin
and the effect of lignin odification on the drug release rate. Lignin odification as conducted via
carboxylation of lignin functional groups. In order to analyze the carboxyl groups in the structure of
lignin and carboxylated lignin, an FTIR test as carried out and the results de onstrated a successful
carboxylation. The dissolution results illustrate that there is a higher release rate of paraceta ol fro
carboxylated lignin tablets, and this is attributed to the lower degree of interaction between lignin and
the API due to the deprotonation of –COOH groups from modified lignin. Furthermore, the controlled
release behavior of carboxylated lignin was evaluated at gastric pH of 1.2 and intestine pH of 7.2,
and the release results showed the successful properties of controlled release. Additionally, the tablet
disintegration tests showed a faster disintegration time for the carboxylated lignin tablets compared to
pure lignin tablets due to the lower hardness of tablets with modified lignin. Thus, these investigations
presented a successful use of carboxylated lignin natural biopolymer as an excipient in oral dosage
forms for desired drug controlled-release.
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